Huada Technology: The controlling shareholder intends to reduce the company’s shares by no more than 2%.

　　() On the evening of July 5, it was announced that Chen Jinghong, the controlling shareholder, actual controller and chairman of the company, planned to reduce the company’s shares by no more than 2%.

　　Longyuan construction: winning the bid for Ruian construction headquarters building and transportation hub project.

　　() The announcement was made on the evening of July 5th. Recently, we received the bid-winning notice issued by Rui ‘an Dongxin Production City Development and Construction Investment Co., Ltd., which is the bid-winning unit of Rui ‘an Construction Headquarters Building and Transportation Hub Project, with the bid amount of 340 million yuan and the construction period of 1095 days.

　　Guoxin Technology: The internal test of the new product of quantum cipher card developed was successful.

　　Guoxin Technology announced on the evening of July 5 that the internal test of the new quantum cipher card jointly developed by the company and Hefei Silicon Zhen, a shareholding company, was successful. After the successful development of this new product, the company and Hefei Silicon Zhen will jointly produce and market this new quantum cipher card.

　　The relatives of Yu Linzhong, the supervisor of Tongkun Co., Ltd., bought and sold stocks to form short-term transactions.

　　() Announcement: On July 5, 2022, the company received the "Explanation and Apology Letter on the Short-term Trading of Company Stocks by My Relatives" issued by Mr. Yu Linzhong, the supervisor of the company. Mr. Yu Linzhong served as the supervisor of the Eighth Board of Supervisors of the Company from June 22, 2020. During the period from August 23, 2021 to June 28, 2022, his spouse, Ms. Shen Aiwen, bought and sold the company’s shares. The above transactions constituted short-term transactions, and some transactions were within the disclosure window of the company’s annual report and performance report, which constituted sensitive transactions. The relevant transaction was caused by Ms. Shen Aiwen’s ignorance of relevant laws and regulations, and Mr. Yu Linzhong did not know the relevant situation in advance and did not inform his relatives about the company’s operation.

　　Jiaao Environmental Protection plans to invest 10 million yuan to set up Sun Company.

　　() Announce that Zhejiang Dongjiang Energy Technology Co., Ltd., a wholly-owned subsidiary of the company, will invest 10 million yuan to set up a subsidiary Zhejiang Xindongjiang Energy Co., Ltd. The above name is tentative, subject to the final approval and registration.

　　Shenma shares received value-added tax to offset the tax refund of 124 million yuan.

　　() Announcement, the company and its subsidiaries have recently received a total of 124 million yuan of VAT refund after applying to the competent tax authorities.

　　Chen Jinghong, the controlling shareholder of Huada Technology, intends to reduce its holdings by no more than 2%.

　　Huada Technology announced that Mr. Chen Jinghong, the controlling shareholder, actual controller and chairman of the company, intends to reduce his holding of the company’s shares by means of centralized bidding transactions by no more than 8,780,800 shares, that is, no more than 2% of the company’s total share capital.

　　In the second quarter, Anbiping obtained three domestic Class I medical device filing certificates.

　　An Biping announced that from April to June 2022, the company and its subsidiaries obtained 3 domestic Class I medical device registration certificates, 5 intellectual property qualifications and 1 overseas certification.

　　Zhejiang Medicine: A subsidiary of Xinma Bio-B increased its capital and introduced ten war investments.

　　() On the evening of July 5th, it was announced that the subsidiary Xinma Bio-B round of capital increase introduced ten strategic investors, including Advanced Manufacturing Industry Investment Fund Phase II (limited partnership), Li ‘an Xinshao Co., Ltd., Suzhou Lirun Equity Investment Center (limited partnership) and (). The investors intend to increase the capital of Xinma Bio with a total capital increase of 400 million yuan or equivalent US dollars, and subscribe for the newly-increased registered capital of Xinma Bio of 3.626 million yuan (the remaining capital increase is included in the capital of the target company)

　　Guoxin Technology: The internal test of the new quantum cipher card product was successful or had a positive impact.

　　Guoxin Technology announced that the quantum cipher card jointly developed by the company and its shareholding company Hefei Silicon Chip Technology Co., Ltd. (referred to as "Hefei Silicon Chip") has been successfully tested in the company recently.

　　After the successful development of this new product, the company and Hefei Silicon Zhen will jointly produce and market the new quantum cipher card. With the successful research and development of this new product, it has filled the blank of this kind of products in the company and enriched the product line of the company, and it is one of the earliest enterprises in the domestic manufacturers.

　　The company said that it will focus on the combination of quantum technology and commercial security products, and actively apply and promote products that use quantum technology to strengthen information security protection, which will have a positive impact on the market expansion and performance growth of the company’s future information security business.

　　Nanshan Group, the controlling shareholder of Hengtong, pledged 21 million shares.

　　() Announcement: Nanshan Group Co., Ltd. ("Nanshan Group"), the controlling shareholder of the company, released the pledge of 21 million shares on July 4, 2022, accounting for 26.18% of its shares and 5.31% of the company’s total share capital.

　　Longyuan Construction won the bid for Ruian Construction Headquarters Building and Transportation Hub Project with a bid price of 340 million yuan.

　　Longyuan Construction announced that the company recently received the bid-winning notice issued by Rui ‘an Dongxin Production City Development and Construction Investment Co., Ltd. The company is the winning bidder of Rui ‘an Construction Industry Headquarters Building and Transportation Hub Project, and the tenderer is Rui ‘an Dongxin Production City Development and Construction Investment Co., Ltd.

　　According to the announcement, the construction site is located in Xincheng Street, Ruian City, east of Gangkou Avenue, south of Xinxing Road, west of Xingye Road and north of Nangeli. The total construction area is 99,400 ㎡, the bid price is 340 million yuan, and the construction period is 1,095 calendar days.

　　Zhejiang Medicine: A subsidiary of Xinma Bio-B increased its capital and introduced strategic investors.

　　On July 5th, the financial sector reported that Zhejiang Pharmaceutical announced that the second round of capital increase of its subsidiary Xinma Bio introduced ten strategic investors, including Advanced Manufacturing Industry Investment Fund Phase II (limited partnership), Li ‘an Xinshao Co., Ltd., Suzhou Lirun Equity Investment Center (limited partnership) and Runtu Co., Ltd., and the investors planned to increase the capital of the target company with a total capital increase of 400 million yuan or equivalent US dollars, and subscribed for the newly-increased registered capital of the target company of 3.626 million yuan (the remaining capital increase was included in the capital reserve of the target company)

　　Xinma Bio, a subsidiary of Zhejiang Pharmaceutical, received a capital increase of 401.5 million yuan in the B round.

　　Zhejiang Pharmaceutical announced that Zhejiang Xinma Biomedical Co., Ltd. ("Xinma Bio"), a subsidiary of the company, and Novocodex, a wholly-owned subsidiary of Xinma Bio, Inc. and the founders of Xinma Bio, Mr. Liang Xuejun, Mr. Xia Gang and other existing shareholders, and advanced manufacturing industry investment fund Phase II (limited partnership), LAV Novo Hong Kong Limited, Suzhou Lirun Equity Investment Center (limited partnership), Zhejiang Runtu Co., Ltd., Hangzhou Saizhi Chuangyun Phase II Equity Investment Partnership (limited partnership), Ten strategic investors from Xinchang Huayu Zhexin Boyuan Talent Venture Capital Partnership (Limited Partnership), Xinchang Zhexin Ruibo Innovation Venture Capital Partnership (Limited Partnership), Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund Partnership (Limited Partnership), Ningbo Ruihu Equity Investment Partnership (Limited Partnership) and Zhuji Hongqi Equity Investment Partnership (Limited Partnership), through friendly negotiation, It is planned to sign the B-round Capital Increase Agreement on Zhejiang Xinma Biomedical Co., Ltd. and the B-round Shareholders Agreement on Zhejiang Xinma Biomedical Co., Ltd., and the investors intend to increase the capital of the target company with a total capital increase of 401.5 million yuan or equivalent US dollars, subscribe for the newly-increased registered capital of the target company of 3,625,800 yuan (the remaining capital increase is included in the capital reserve of the target company), and obtain about 129,454% equity of the target company after the capital increase.

　　It is said that after the A round of financing, the target company has successively completed a number of milestone progress, including: 1) the completion of the mid-term results analysis of ARX788 breast cancer II/III; 2) Initiate the phase II/III clinical study of ARX788 gastric cancer; 3) Finish the IND declaration of the second ADC product ARX305; 4) NCB003 products developed on the platform of independent intellectual property rights have completed the trial production of toxicological samples in the pilot base, and the production of clinical batch samples will soon be completed; 5) Submitted 10 invention patent applications including new products and new unnatural amino acids.

　　Shan Ying International’s domestic paper sales in June was 506,900 tons, down 0.46% year-on-year.

　　() Announced that the domestic paper sales of the company in June 2022 was 506,900 tons, down 0.46% year-on-year; In the first six months, the sales volume was 2,716,800 tons, down 3.38% year-on-year.

　　Saiteng shares granted 9.118 million restricted shares to the incentive object.

　　() Announcement was issued, and the board of directors of the company determined that the award date of this incentive plan was July 5, 2022, and 9.118 million restricted shares were awarded to 335 incentive targets at a price of 9.43 yuan/share.

　　An Biping: Recently obtained a number of medical qualifications.

　　An Biping announced that from April to June 2022, the company and its subsidiaries obtained 3 domestic Class I medical device registration certificates, 5 intellectual property qualifications and 1 overseas certification. The acquisition of the above qualifications is conducive to expanding the company’s product layout in the field of tumor screening and accurate diagnosis.

　　Heshun Petroleum: Tongguan Oil Depot and Heshun Petroleum Tongguan Trading Center put into operation.

　　() Announcement: The "Changsha Tongguan Oil Depot Construction Project" (hereinafter referred to as "Tongguan Oil Depot"), an investment project of the company’s initial public offering of raised funds, is a Tongguan Oil Depot project built by Hunan Heshun Tongguan Petroleum Co., Ltd., a wholly-owned subsidiary. Tongguan Oil Depot and Heshun Petroleum Tongguan Trading Center were officially put into operation on July 5, 2022.

　　The controlling shareholder of Huada Technology intends to reduce its shareholding by no more than 2% through centralized bidding.

　　Huada Technology announced that the controlling shareholder Chen Jinghong intends to reduce his holding of the company’s shares by no more than 8,780,800 shares, that is, no more than 2% of the company’s total share capital.

　　The application for issuing convertible bonds by Gaoce shares was approved by the China Securities Regulatory Commission for registration.

　　Gaoce shares announcement, the company recently received the "Reply on Approving Qingdao Gaoce Technology Co., Ltd. to issue convertible corporate bonds to unspecified objects for registration" issued by China Securities Regulatory Commission. The reply is valid for 12 months from the date of consent to registration.

　　Zhu Mingrui, the newly hired fund manager of Nordisk Xinwang, fell 16.6% during the management year.

　　China Economic Net, Beijing, July 5-Recently, Nord Fund Management Co., Ltd. announced that Zhu Mingrui, an additional fund manager, was hired to manage Nord Xinwang’s flexible allocation of hybrid funds.

　　According to the data, Zhu Mingrui has served as a medical investment researcher of Debon Securities Co., Ltd. and a medical investment researcher of Shanghai Asset Management Branch of Guojin Securities Co., Ltd. In March 2021, he joined Nord Fund Management Co., Ltd. as a pharmaceutical investment researcher with fund qualification.

　　Nord Xinwang was established on February 7, 2018. As of July 4, 2022, the rate of return this year was -16.63%. Since its establishment, the rate of return has been 41.94%, with a cumulative net value of 1.4194 yuan.

　　() The holding subsidiary intends to sign the Financial Services Agreement with the controlling shareholder.

　　Zhongnan Media announced that in order to give full play to the fund management and financial leverage of finance companies and give full play to the role of financial capital in promoting industrial capital, Hunan Publishing Investment Holding Group Finance Co., Ltd. ("Finance Company"), a holding subsidiary of the company, plans to sign a Financial Services Agreement with Hunan Publishing Investment Holding Group Co., Ltd. ("Holding Group") to provide relevant financial services for the holding group, including but not limited to deposit services, loan services and settlement services. It is estimated that in 2022, the average daily deposit balance of the holding group in financial companies will not exceed 2.2 billion yuan (inclusive).

　　It is reported that this transaction is conducive to integrating capital resources, broadening the company’s financing channels, reducing the company’s capital cost and management risks, and maximizing the overall benefit of capital management, which is in line with the company’s consortium development strategy and the long-term interests of shareholders.

　　Zhongnan Media plans to permanently replenish its working capital with interest of 522 million yuan from over-raised funds.

　　Zhongnan Media announced that in order to improve the efficiency of the use of funds raised by the company, better provide financial support for the expansion of the company’s core business scale, and promote the company’s sustained and healthy development, the company plans to use the interest of over-raised funds of 522 million yuan to permanently replenish liquidity for the parent company and 11 wholly-owned subsidiaries, including 246 million yuan for the parent company and 276 million yuan for the 11 wholly-owned subsidiaries by way of capital increase.

　　Jianzhijia: Four shareholders plan to reduce their holdings by no more than 7.03% in total.

　　() On the evening of July 5th, it was announced that Chengdeye Partnership, Suzhou Heju Rongyi, Suzhou Heju Huiyi and Suzhou Heyi planned to reduce their holdings by no more than 7.03%. Among the above-mentioned reduction subjects, Suzhou and Jurongyi, Suzhou and Juhuiyi, and Suzhou Heyi have a concerted relationship.

　　Relevant shareholders of Jianzhijia intend to reduce their holdings by no more than 7% in total.

　　Jianzhijia announced that according to the voluntary commitment of Chengdeye Partnership before the company’s initial public offering and listing, due to its own capital needs, it plans to reduce its holdings of no more than 2,621,200 shares directly held by it through call auction and block trading within six months after the announcement of this reduction plan, that is, no more than 26,413% of the total shares of the company, and the reduction price is determined according to the market price.

　　Suzhou Heju Rongyi, Suzhou Heju Huiyi and Suzhou Heyi are all enterprises under the same control of Suzhou Hezheng Equity Investment Fund Management Company (Limited Partnership). According to the voluntary commitments of the first three companies of the company’s initial public offering, due to their own financial needs, they intend to reduce their holdings by call auction and block trading within six months after the announcement of this reduction plan, which will not exceed 4.36 million shares of the company directly held by them, that is, 43,900 shares of the company.

　　The flexible configuration of Beixin Ruifeng Ping ‘an China theme will replace Zou Jie’s departure and hire Shi Chu.

　　Today, Beixin Ruifeng Fund Management Co., Ltd. announced the change of fund manager. Beixin Ruifeng Ping An China Theme Flexible Allocation Hybrid Securities Investment Fund (referred to as "Beixin Ruifeng Ping An China Theme Flexible Allocation") hired Shi Chu, the former fund manager, and Zou Jie left for personal reasons.

　　Shi Chu, Ph.D. student in marine engineering of Shanghai Jiaotong University, has 5 years’ experience in securities fund industry. He used to be a researcher of Junzheng Capital Management Co., Ltd., engaged in the research work of science and technology industry. In May 2020, he joined Beixin Ruifeng Fund Management Co., Ltd. and successively served as an industry researcher in the equity research department and an assistant fund manager in the equity investment department. He is currently the fund manager of the company’s equity investment department.

　　Zou Jie, doctor of engineering from Shanghai Jiaotong University, was an assistant analyst of Debon Securities Co., Ltd., an analyst of communication industry of Industrial Securities Co., Ltd. and an assistant fund manager of Hongyi Yuanfang Fund Management Co., Ltd. In June 2020, he joined Beixin Ruifeng Fund Management Co., Ltd. as the assistant fund manager of the equity investment department, and now he is the fund manager of the equity investment department. From May 6, 2021 to July 4, 2022, he served as the fund manager of Beixin Ruifeng Ping An China Theme Flexible Allocation Hybrid Securities Investment Fund. He used to be the fund manager of Beixin Ruifeng New Growth Flexible Allocation Hybrid Securities Investment Fund.

　　Beixin Ruifeng Ping ‘an China was established on May 5, 2015. As of July 4, 2022, it has fallen by 5.02% this year, with a yield of 32.50% since its establishment and a cumulative net value of 1.3250 yuan.

　　The distribution of Jiuzhou Pharmaceutical’s rights and interests is planned to be 0.25 yuan per share, with ex-dividend on July 13.

　　() Announce that this profit distribution is based on the total share capital of the company before the implementation of the plan, and a cash dividend of 0.25 yuan (including tax) will be distributed per share.

　　This time, the distribution of rights and interests in date of record is July 12, 2022, and the ex-dividend date is July 13, 2022.

　　() The volume and price of pre-earnings are rising. It is estimated that the semi-annual net profit will be 2.5 billion to 2.6 billion yuan, increasing by 149% to 159% year-on-year.

　　Meihua Bio disclosed the announcement of pre-increase of semi-annual results in 2022. The company expects the net profit attributable to shareholders of listed companies to be 2.5 billion to 2.6 billion yuan in the half year, up 149% to 159% year-on-year. It is estimated that the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is 2.48 billion to 2.58 billion yuan, an increase of 155% to 165% year-on-year.

　　During the reporting period, the company’s performance growth mainly came from the growth of operating profit. The continuous growth of the company’s business has brought about an increase in main business income and profit: in the first half of 2022, the prices of the company’s main raw materials continued to rise to varying degrees compared with the same period, and the company continuously improved its management level. In addition, the prices of main products such as monosodium glutamate, threonine, lysine, xanthan gum and other feed amino acid products increased; During the reporting period, the lysine production capacity of Jilin Meihua Phase III, a subsidiary of the company, was released, and the scale of lysine was further expanded; To sum up, the company’s overall profitability has been further enhanced and profits have increased.

　　SINOMACH: Signed a 203 million yuan contract for intelligent renovation of chassis assembly workshop.

　　() On the evening of July 5th, it was announced that a wholly-owned subsidiary, China Automobile Engineering, and SAIC hongyan automobile Co., Ltd. signed the General Contract of SAIC Hongyan Vehicle Capacity Expansion Project-Intelligent Reconstruction Project of Chassis Assembly Workshop, with a contract price of 203 million yuan.

　　SINOMACH: Signed a 203 million yuan contract for intelligent renovation of chassis assembly workshop.

　　On the evening of July 5th, SINOMACH announced that its wholly-owned subsidiary, China Automobile Engineering, and SAIC hongyan automobile Co., Ltd. signed the General Contract of SAIC Hongyan Vehicle Capacity Expansion Project-Intelligent Reconstruction Project of Chassis Assembly Workshop, with a contract price of 203 million yuan.

　　Huatai shares spent 144 million yuan to buy back 2.12% of the shares.

　　() Announcement was issued. As of July 5, 2022, the company repurchased 24.797 million shares through centralized bidding, accounting for 2.12% of the company’s current total share capital. The highest transaction price was 5.94 yuan/share, the lowest transaction price was 5.56 yuan/share, and the total amount of funds paid was 144 million yuan (excluding stamp duty, trading commission and other related expenses).

　　Kemei Diagnosis: Ping An Real Estate and its concerted parties intend to reduce their holdings by no more than 3%.

　　Kemei Diagnostics announced on the evening of July 5 that Ping An Real Estate, a shareholder with a total shareholding of 8.5%, and its concerted action, Pingsheng Ankang, intend to reduce their holdings by no more than 3%.

　　Beixin Ruifeng’s new growth Zou Jie left and hired Zhang Wenbo, which fell by 20% during the year.

　　Today, Beixin Ruifeng Fund Management Co., Ltd. announced the change of fund manager. Beixin Ruifeng New Growth hired Zhang Wenbo, the fund manager, and Zou Jie left for personal reasons.

　　Zhang Wenbo holds a master’s degree in finance in Peking University and has 7 years’ experience in securities fund industry. He used to be a researcher of Changsheng Fund Management Co., Ltd., and joined Beixin Ruifeng Fund Management Co., Ltd. as a researcher in April 2016. He is currently the fund manager of equity investment department of Beixin Ruifeng Fund Management Co., Ltd.

　　Zou Jie holds a doctor’s degree in engineering from Shanghai Jiaotong University. He used to be an assistant analyst of Debon Securities Co., Ltd., a communications industry analyst of Industrial Securities Co., Ltd. and an assistant fund manager of Hongyi Yuanfang Fund Management Co., Ltd. In June 2020, he joined Beixin Ruifeng Fund Management Co., Ltd. as the assistant fund manager of the equity investment department, and is currently the fund manager of the equity investment department.

　　Beixin Ruifeng New Growth was established on November 11, 2015. As of July 4, 2022, its rate of return this year was -20.32%, its rate of return since its establishment was 67.50%, and its accumulated net value was 1.6520 yuan.

　　Kemei Diagnostics shareholder Ping An Real Estate plans to reduce its shareholding by no more than 3%.

　　Kemei Diagnostics announced that due to the shareholders’ own capital needs, Ping An Real Estate and its concerted action Pingsheng Ankang intend to reduce the company’s shares by centralized bidding and block trading, with a total reduction of no more than 12.03 million shares and a total reduction of no more than 3.00% of the company’s total share capital.

　　Jinan High-tech: The subsidiary real-time fluorescence quantitative PCR instrument obtained the medical device registration certificate.

　　() On the evening of July 5th, it was announced that Aikewei Bio, a holding subsidiary, received the Medical Device Registration Certificate of Real-time Fluorescence Quantitative PCR Instrument issued by National Medical Products Administration. The real-time fluorescence quantitative PCR analyzer independently developed by Ackerway Bio can be used together with the matching nucleic acid detection reagents, which can carry out rapid and accurate quantitative and qualitative detection and has a wide range of applications.

　　() Distribution of rights and interests in 2021: 0.08 yuan will be paid for 0.2 shares per share, and ex-dividend will be paid on July 13th.

　　Gm shares announced that the company will implement the annual equity distribution in 2021, with a cash dividend of 0.08 yuan (including tax) per share, and 0.2 shares will be transferred from the capital reserve. The date of record of this equity distribution is July 12, 2022, and the ex-dividend date and cash dividend payment date are July 13, 2022.

　　SINOMACH’s subsidiary signed the related contract of 203 million yuan SAIC Hongyan vehicle capacity expansion project.

　　SINOMACH announced that China Automotive Industry Engineering Co., Ltd. (hereinafter referred to as "China Automotive Engineering"), a wholly-owned subsidiary of SINOMACH, signed the General Contract of SAIC Hongyan Vehicle Expansion Project-Intelligent Reconstruction Project of Chassis Assembly Workshop with a contract price of 203 million yuan (including tax) on July 5, 2022. The project overview is as follows:

　　Intelligently transform the chassis assembly workshop to improve the vehicle production capacity and meet the production of all kinds of driving models, new energy vehicles, smart heavy trucks and other vehicles. This project is a turnkey project, which mainly includes the whole process of project construction, such as approval and construction procedures, construction drawing design, special approval, project construction, procurement of professional equipment and materials, etc.

　　According to the announcement, the signing of the contract will have a positive impact on the company’s operating performance during the contract performance period, which is conducive to enhancing the competitiveness of the company’s general contracting business in the heavy truck market and further deepening the strategic cooperation relationship with ().

　　SINOMACH’s subsidiary signed the related contract of 203 million yuan SAIC Hongyan vehicle capacity expansion project.

　　SINOMACH announced that China Automotive Industry Engineering Co., Ltd. (hereinafter referred to as "China Automotive Engineering"), a wholly-owned subsidiary of SINOMACH, signed the General Contract of SAIC Hongyan Vehicle Expansion Project-Intelligent Reconstruction Project of Chassis Assembly Workshop with a contract price of 203 million yuan (including tax) on July 5, 2022. The project overview is as follows:

　　Intelligently transform the chassis assembly workshop to improve the vehicle production capacity and meet the production of all kinds of driving models, new energy vehicles, smart heavy trucks and other vehicles. This project is a turnkey project, which mainly includes the whole process of project construction, such as approval and construction procedures, construction drawing design, special approval, project construction, procurement of professional equipment and materials, etc.

　　According to the announcement, the signing of the contract will have a positive impact on the company’s operating performance during the contract performance period, which is conducive to enhancing the company’s competitiveness in the general contracting business in the heavy truck market and further deepening the strategic cooperative relationship with SAIC.

　　Fengzhu Textile will distribute a cash dividend of 0.0808 yuan per share on July 12th.

　　() Announced that this profit distribution is based on the company’s total share capital of 272 million shares before the implementation of the plan, with a cash dividend of 0.0808 yuan (including tax) per share, with a total cash dividend of 21,977,600 yuan. Date of record is July 11, 2022, and the ex-dividend date is July 12, 2022. All shareholders of the Company registered in Shanghai Branch of China Securities Depository and Clearing Co., Ltd. after the closing of Shanghai Stock Exchange in date of record afternoon.

　　High-energy environment: jointly won the bid for groundwater pollution prevention and control project in Songyi mining area.

　　() On the evening of July 5th, it was announced that the consortium with the company as the lead party won the bid for the "Pilot Project of Groundwater Pollution Prevention and Control in Songyi Mining Area (Phase I) EPC". The maximum bid price limit is 63.3 million yuan.

　　Several shareholders of Jianzhijia intend to reduce their holdings by no more than 7.03% in total.

　　(Reporter Ma Huanhuan) On the evening of July 5, Jianzhijia disclosed that the company’s shareholders Chengdeye Partnership, Suzhou Heju Rongyi, Suzhou Heju Huiyi and Suzhou Heyi intend to reduce their holdings by no more than 7.03%.

　　As of the close of July 5, the share price of Jianzhijia was 46.49 yuan/share, with a total market value of 4.614 billion yuan.

　　SINOMACH: Signed a 203 million yuan general contract for intelligent renovation project of chassis assembly workshop.

　　On July 5th, the financial sector announced that SINOMACH had signed the General Contract of SAIC Hongyan Vehicle Capacity Expansion Project-Intelligent Renovation Project of Chassis Assembly Workshop with a contract price of 203 million yuan.

　　SINOMACH: Signed a 203 million yuan general contract for intelligent renovation project of chassis assembly workshop.

　　On July 5th, the financial sector announced that SINOMACH had signed the General Contract of SAIC Hongyan Vehicle Capacity Expansion Project-Intelligent Renovation Project of Chassis Assembly Workshop with a contract price of 203 million yuan.

　　Jinan High-tech Subsidiary Obtained Medical Device Registration Certificate

　　Jinan Hi-tech announced that recently, Shandong Aikewei Biotechnology Co., Ltd. (referred to as "Aikewei Bio"), a holding subsidiary of the company, received the Medical Device Registration Certificate issued by National Medical Products Administration, and the product name was Real-time Fluorescence Quantitative PCR Instrument.

　　Scope of application: This product can be used together with matching nucleic acid detection reagents, and can be used for quantitative and qualitative detection of target nucleic acid (DNA/RNA) in human whole blood, serum/plasma, oropharyngeal swab, sputum and feces samples, including pathogen and human gene mutation and typing items.

　　The High Energy Environment Consortium won the bid for the groundwater treatment project in Songzi City.

　　The announcement of high-energy environment was made. Today, the company received the Notice of Winning Bid from Hubei Mingda Engineering Consulting Co., Ltd., a bidding agency, which confirmed that the company, as the leader of the consortium, was the winning bidder of the "EPC Project of Groundwater Pollution Prevention and Control in Songyi Mining Area (Phase I)".

　　It is reported that according to the bidding documents of the project, this project adopts the rate quotation method to bid, and the maximum bid price limit is 63.3 million yuan. The company’s bid-winning rate quotation is: design quotation 59.65%, survey quotation 49.21% and construction quotation 89.56%. (The final amount is subject to the amount agreed in the contract)

　　Mo Ruiwei and Wang Yun, shareholders of baby-friendly room, plan to reduce their holdings by no more than 384,100 shares.

　　() Announced that Mr. Mo Ruiwei, the concerted action person of Shanghai Maoqiang Investment Management Partnership (Limited Partnership) (hereinafter referred to as "Maoqiang Investment"), the company’s specific shareholder, intends to reduce his holding of the company’s shares by centralized bidding or block trading within 6 months after 15 trading days from the date of announcement, with a maximum of 259,100 shares, accounting for 0.18% of the company’s total share capital.

　　Ms. Wang Yun, the director and senior vice president of the company, intends to reduce her holding of the company’s shares by centralized bidding or block trading within six months after the announcement, with a maximum of 125,000 shares, accounting for 0.09% of the company’s total share capital.

　　Haohua Technology will pay the cash dividend of 0.2911 yuan per share in 2021 on July 13th.

　　() Announcement: On July 13th, 2022, the company will pay the cash dividend for 2021, with 0.29110 yuan (including tax) per share. The date of record of this equity distribution is July 12, 2022, and the ex-dividend date is July 13, 2022.

　　Kemei diagnosis: Ping An Real Estate and the consensus plan to reduce their holdings by no more than 3%.

　　The financial sector announced on July 5 that Kemei Diagnostics announced that Ping An Real Estate and Pingsheng Ankang, the unanimous person, intend to reduce their holdings by no more than 3%.

　　The distribution of rights and interests of State Grid ICT is planned to be 0.17 yuan per share, which will be ex-dividend on July 14th.

　　() Announce that this profit distribution is based on the total share capital of the company before the implementation of the plan, and a cash dividend of 0.17 yuan (including tax) will be distributed per share.

　　The date of this equity distribution in date of record is July 13th, 2022, and the ex-dividend date is July 14th, 2022.

　　Emma Technology: It is planned to invest 1.15 billion yuan to build Emma Smart Travel Industrial Park project.

　　() On the evening of July 5th, it was announced that the company planned to invest in the construction of Emma Smart Travel Industrial Park in Guigang, with a total planned investment of about 1.15 billion yuan. The project is planned to be actually implemented by Guangxi Emma Vehicle Co., Ltd., a wholly-owned subsidiary.

　　China Resources Shuanghe: "Nifedipine Controlled Release Tablets" obtained the drug registration certificate.

　　() Announcement: Recently, China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. ("Shuanghe Limin"), a wholly-owned subsidiary of the company, received the "nifedipine controlled-release tablets" and the Drug Registration Certificate (certificate number: 2022S00637) issued by National Medical Products Administration, and approved the production of this drug.

　　It is reported that nifedipine controlled release tablets are suitable for: hypertension; Coronary heart disease; Chronic stable angina pectoris (angina pectoris). In the domestic market, according to the information on the website of National Medical Products Administration, there are 13 companies (including Double Crane and Limin) that have been approved for listing in Chinese mainland.

　　Wu Zhengui, director of Heli Technology, has reduced his holdings of 146,100 shares by more than half.

　　() Announcement. As of the disclosure date of this announcement, Mr. Wu Zhengui, the director of the company, has reduced his holdings of 146,100 shares by centralized bidding during the reduction period, with a reduction ratio of 0.09%. More than half of the shares are reduced this time, and the reduction plan has not yet been implemented.

　　Xingfa Group’s net profit increased by 217%-226% in the first half of the year, and the demand for products was strong.

　　() Announced on the evening of July 5th, it is estimated that the half-year net profit in 2022 will be 3.62 billion to 3.72 billion yuan, up by 217.31% to 226.08% year-on-year. The company said that in the first half of the year, although the sales prices of chemical and agrochemical products such as glyphosate, phosphate rock, yellow phosphorus and phosphate fertilizer fluctuated, they generally remained at a high level. The company has a strong demand for fine phosphorus and sulfur chemical products such as food-grade phosphate and dimethyl sulfoxide, and wet electronic chemicals such as IC-grade phosphoric acid, sulfuric acid and mixed solution, which has significantly improved its profitability and greatly increased its operating efficiency.

　　42 million restricted shares of Litong Electronics will be listed and circulated on July 11th.

　　() Announced that the number of restricted shares listed and circulated by the company this time is 42 million shares, and the date of listing and circulation of restricted shares this time is July 11, 2022.

　　The net profit of Meihua Bio increased by 149%-159% in the first half of the year, and the lysine production capacity was released.

　　Meihua Bio announced on the evening of July 5 that it is estimated that the net profit returned to the mother in the first half of 2022 will be 2.5 billion yuan to 2.6 billion yuan, an increase of 149% to 159% year-on-year. During the reporting period, the lysine production capacity of Jilin Meihua Phase III, a subsidiary of the company, was released, and the scale of lysine was further expanded.

　　Distribution of rights and interests of New Huangpu in 2021: 0.05 yuan per share, and equity registration on July 12.

　　() Announced that the company’s annual equity distribution in 2021 will be implemented: based on the total share capital of the company before the implementation of the plan, a cash dividend of 0.05 yuan (including tax) will be distributed per share, with date of record on July 12, 2022 and ex-dividend date on July 13, 2022.

　　Baili Electric will distribute the 2021 cash dividend of 0.029 yuan per share on July 12th.

　　() Announced that this profit distribution is based on the company’s total share capital of 1.088 billion shares before the implementation of the plan, with a cash dividend of 0.029 yuan (including tax) per share, with a total cash dividend of 31.5443 million yuan. Date of record is on July 11, 2022, and the ex-dividend date is July 12, 2022. The distribution targets are all shareholders of the company registered in Shanghai Branch of China Securities Depository and Clearing Co., Ltd. after the closing of the Shanghai Stock Exchange in date of record afternoon.

　　29,632,200 restricted shares of Weili Medical will be listed and circulated on July 11th.

　　() Announced that the number of restricted shares listed and circulated by the company this time is 29,632,200 shares, and the date of listing and circulation of restricted shares this time is July 11, 2022.

　　Lifan Technology: 12,547 new energy vehicles were sold in the first half of the year.

　　() It was announced on the evening of July 5 that 3,126 new energy vehicles were sold in June; This year, 12,547 vehicles were sold, up 11,626.17% year-on-year.

　　Chen Yi Cheng Yu and Defu Zhong Teng spent 490 million yuan to participate in the capital increase and share expansion of Haizheng Pharmaceutical Subsidiary and the transfer of old shares.

　　() Announcement, as disclosed in the previous announcement, the company intends to increase capital and share and transfer some old shares to Zhejiang Haizheng Animal Health Products Co., Ltd. ("Haizheng Animal Health Insurance"), a holding subsidiary. This capital increase and share expansion and the transfer of old shares are planned to be based on the pre-investment valuation of not less than 2.2 billion yuan, and the planned capital increase is not more than 47.7273 million yuan, with a total capital increase of 300 million yuan; The transfer of old shares does not exceed the registered capital of 30.2273 million yuan, and the total transfer price is 190 million yuan. The transaction was conducted in the form of public listing, and the reserve price of listing was not less than 6.2857 yuan/share.

　　On July 5, 2022, Taizhou Property Rights Exchange Co., Ltd. ("Taiwan Stock Exchange") confirmed that Wuxi Chenyi Chengyu Consulting Management Partnership ("Chenyi Chengyu") and Xiamen Defu Zhongteng Investment Partnership ("Defu Zhongteng") were jointly delisted, and the registered capital of Haizheng Dynamic Insurance held by Haizheng Pharmaceutical was 30,227,300 yuan, with a transaction price of 1.9. The subscription of Haizheng Animal Health Insurance increased the registered capital by 47,727,300 yuan, and the transaction price of capital increase was 300 million yuan, and the equity transfer contract of Zhejiang Haizheng Animal Health Care Co., Ltd. and the capital increase agreement of Zhejiang Haizheng Animal Health Care Co., Ltd. were signed with the company and Haizheng Animal Health Care Insurance.

　　It is reported that Chenyi Chengyu and Telford Zhongteng are both limited partnerships registered in China, and there is no financial data yet. After the completion of the transaction of Haizheng Dynamic Insurance’s capital increase and share expansion and the transfer of old shares, Haizheng Pharmaceutical still holds 70.343% equity of Haizheng Dynamic Insurance and remains its controlling shareholder, and continues to consolidate Haizheng Dynamic Insurance’s statements.

　　The shareholders of Jianzhijia intend to reduce their holdings by no more than 7.03% in total.

　　Jianzhijia announced that the shareholder Chengde Industry Partnership intends to reduce the company’s shares by no more than 2.6413% of the company’s total shares; Shareholders Suzhou Heju Rongyi and their concerted actions Suzhou Heju Huiyi and Suzhou Heyi intend to reduce the shares of the company by no more than 4.3934% of the total shares of the company.

　　Zhongke Tongda: 55,228,100 restricted shares will be listed and circulated on July 13th.

　　Zhongke Tongda announced the listing and circulation of some restricted shares in the initial public offering. The number of restricted shares listed and circulated this time is 55.2281 million shares, accounting for 47.4577% of the total share capital of the company at present, and the listing and circulation date is July 13, 2022.

　　Xiagong Co., Ltd.: Sun Tao applied to resign as vice president of the company for personal reasons.

　　Announcement on July 5th-() said that after receiving the written resignation report submitted by Sun Tao, the vice president of the company, Sun Tao applied to resign as the vice president of the company for personal reasons, and will not hold other positions in the company after his resignation.

　　The distribution of rights and interests of Silanwei is planned to send 0.1 yuan ex-dividend on July 13.

　　() Announce that this profit distribution is based on the total share capital of the company before the implementation of the plan, and a cash dividend of 0.1 yuan (including tax) will be distributed per share.

　　This time, the distribution of rights and interests in date of record is July 12, 2022, and the ex-dividend date is July 13, 2022.

　　Shenzhou Cell has accumulated an increase of 564,000 shares by Xie Liangzhi, the actual controller, and Aleck, the controlling shareholder of Lhasa.

　　Shenzhou Cell announced that Dr. Xie Liangzhi, the actual controller, chairman and general manager of the company, and Alec Lhasa, the controlling shareholder, had increased their holdings of 564,000 shares by centralized bidding as of July 5, 2022, accounting for 0.1296% of the company’s total share capital, with a total increase of RMB 29,995,600.

　　Pingmei shares: Zhao Yuntong resigned as chief financial officer.

　　() Announcement, the board of directors of the company recently received a written resignation application from Mr. Zhao Yuntong, the company’s financial controller. Mr. Zhao Yuntong resigned as the company’s financial controller due to job changes, and will continue to serve as the company’s director and member of the audit and strategy Committee after his resignation. According to the relevant provisions of the Company Law and Articles of Association, Mr. Zhao Yuntong’s application for resignation takes effect from the date when it is served on the board of directors of the company.

　　Shanghai Bank intends to grant the major shareholder CCB an investment credit line of no more than 1.5 billion yuan.

　　() Announcement: The company intends to grant a credit line of no more than RMB 1.5 billion to China Jianyin Investment Co., Ltd. ("CCB Investment"), the credit period is not longer than one year, and the credit line can be used for financial bond underwriting, securities holding, investment and corporate bond investment, and the single business period is not longer than five years, and the guarantee method is credit.

　　In the first half of the year, Sichuan Investment Energy Holdings Hydropower Company generated 1.614 billion kWh of electricity, down 10.93% year-on-year.

　　() Disclosure of main operating data from January to June, 2022. From January to June, 2022, the hydropower enterprises controlled by the company completed a total power generation of 1.614 billion kWh, a decrease of 10.93% compared with the previous year, and the on-grid electricity consumption was 1.584 billion kWh, a decrease of 10.91% compared with the previous year; The average on-grid electricity price of hydropower enterprises is 0.23 yuan/kWh, an increase of 4.55% compared with the same period of last year.

　　Reasons for the decrease of power generation and on-grid power from January to June, 2022: Tianwanhe Company, a holding subsidiary of the company, failed to store water in Renzonghai Reservoir at the end of 2021 due to the leakage control project of Renzonghai Dam, which led to the decrease of power generation in the first half of the year. The reason for the fluctuation of average on-grid electricity price: the power marketing of the company is normal in this period, and the average on-grid electricity price fluctuates compared with the same period of last year due to market-oriented electricity sales.

　　Warner Pharmaceutical Factory: 35.338 million restricted shares will be listed and circulated on July 13th.

　　Warner Pharmaceutical announced that the restricted shares listed and circulated this time are the company’s initial public offering of restricted shares and strategic allotment shares, involving a total of 13 shareholders, accounting for 35.338 million shares, accounting for 37.6738% of the company’s total share capital. This part of restricted shares will be listed and circulated on July 13, 2022.

　　The shareholding ratio of Guanghui Logistics shareholder Xi’ an Long Da fell below 5%

　　() Announcement was issued. On July 5, 2022, the company received the Report on Simple Equity Change of Guanghui Logistics Co., Ltd. from the shareholder Xi ‘an Long Da. On July 5, 2022, Xi ‘an Long Da reduced its holding of 400,000 shares of the company by centralized bidding, accounting for 0.03% of the company’s total share capital. After this reduction, the shares held by Xi ‘an Long Da account for 4.99% of the company’s total share capital.

　　Long-term Lithium Branch’s application for issuing convertible bonds was reviewed and approved by Shanghai Stock Exchange’s science and technology innovation board Municipal Committee.

　　Changyuan Lithium announced that on July 5, 2022, the science and technology innovation board Listing Committee of Shanghai Stock Exchange held the 56th deliberation meeting of the Listing Committee in 2022, and reviewed the company’s application for issuing convertible corporate bonds to unspecified objects. According to the results of the meeting, the company’s application for issuing convertible corporate bonds to unspecified objects meets the requirements of issuance, listing and information disclosure.

　　The distribution of rights and interests of Newway shares is planned to be 0.25 yuan per share, with ex-dividend on July 14.

　　() Announce that this profit distribution is based on the total share capital of the company before the implementation of the plan, and a cash dividend of 0.25 yuan (including tax) will be distributed per share.

　　The date of this equity distribution in date of record is July 13th, 2022, and the ex-dividend date is July 14th, 2022.

　　Honghe Technology will pay a cash dividend of 0.0984 yuan per share in 2021 on July 12th.

　　() Announcement: On July 12, 2022, the company will pay the 2021 annual cash dividend of 0.0984 yuan per share (including tax). The date of record of this equity distribution is July 11th, 2022, and the ex-dividend date is July 12th, 2022.

　　Zhichun Technology plans to issue ultra-short-term financing bonds of no more than 200 million yuan.

　　() Announce that in order to meet the company’s production and operation needs, optimize and broaden financing channels, and reduce financing costs, the company intends to apply to the China Association of Interbank Market Dealers for registration and issuance of ultra-short-term financing bonds, with the registered scale not exceeding RMB 200 million (including RMB 200 million).

　　() shortlisted for energy storage system equipment procurement project of Ningxia Jingneng Xuanhe 150MW/300MWh energy storage project.

　　Kelu Electronics announced that the company received the "Short-list Notice" from Shandong Electric Power Construction Co., Ltd., confirming that the company was short-listed for the energy storage system equipment procurement project of Ningxia Jingneng Xuanhe 150MW/300MWh energy storage project of China Electric Power Construction Shandong Electric Power Construction Company, and the winning bid amount was about RMB 410 million. The company has received the Notice of Finalization of the project, but has not yet signed the contract. The specific content shall be subject to the final contract.

　　Hangxiao: Short-term transaction between the mother of executive Song Beibei and the spouse of executive Qin Bo.

　　() Announcement: Recently, the company received the Report and Apology Statement on the Short-term Trading of Company Stocks by My Relatives issued by Song Beibei and Qin Bo, senior managers of the company respectively. Song Beibei’s mother Wang Xiaoyan bought and sold company stocks from December 10, 2021 to December 14, 2021; Qin Bo’s spouse Mao Hongwei bought and sold the company’s shares from October 26, 2021 to June 22, 2022; The above transactions constitute short-term transactions.

　　Sanfu Xinke awarded 8 million stock options to the incentive object at an exercise price of 31.825 yuan/share.

　　Sanfu Xinke announced that the company held the 35th meeting of the 3rd Board of Directors and the 23rd meeting of the 3rd Board of Supervisors on July 5th, 2022, and respectively reviewed and approved the Proposal on Granting Stock Options to Incentive Objects and the Proposal on Adjusting the Grant Price and Exercise Price of the Company’s Restricted Stock in 2021 and the Stock Option Incentive Plan in 2022, and agreed to set July 5th, 2022 as the grant date to award 15 eligible employees.

　　In the first half of the year, China’s nuclear power generated 94.35 billion kWh, up 8.15% year-on-year.

　　() Announced that by June 30, 2022, the company’s nuclear power holding company had 25 units in operation, with an installed capacity of 23.71 million kilowatts; Holding 8 units of the project under construction, with an installed capacity of 8.878 million kilowatts; Holding one approved unit with an installed capacity of 1.251 million kilowatts. The company’s New Energy Holdings has a total of 11.517 million kilowatts of projects under construction (8.8733 million kilowatts of installed capacity in operation and 2.6437 million kilowatts of installed capacity under construction), including 2.999 million kilowatts of wind power and 8.518 million kilowatts of photovoltaic power.

　　As of June 30, 2022, the company’s accumulated commercial power generation in the first half of 2022 was 94.35 billion kWh, an increase of 8.15% year-on-year; The online electricity consumption was 89.479 billion kWh, up 9.53% year-on-year.

　　Aerospace Hongtu received an inquiry letter from Shanghai Stock Exchange about the issue of convertible bonds by the company.

　　Aerospace Hongtu announced that on July 5, 2022, the company received the "Inquiry Letter on Auditing the Application Documents of Aerospace Hongtu Information Technology Co., Ltd. to Issue Convertible Corporate Bonds to Unspecified Objects" ("Inquiry Letter") issued by Shanghai Stock Exchange ("SSE"). The auditing organization of Shanghai Stock Exchange audited the application documents submitted by the company for issuing convertible corporate bonds to unspecified objects, and formed the first round of inquiry questions. It mainly involves several aspects: this fundraising project, financing scale, income calculation, financial investment, operating conditions and others (accounts receivable, gross profit margin, inventory, cash flow from operating activities).

　　Long-term Lithium Company’s application for issuing convertible bonds was reviewed and approved by Shanghai Stock Exchange.

　　Changyuan Lithium announced that on July 5, 2022, the Shanghai Stock Exchange science and technology innovation board Municipal Committee held a review meeting to review the company’s application for issuing convertible bonds to unspecified objects. According to the deliberation results of the meeting, the company’s application for issuing convertible bonds to unspecified objects meets the issuance conditions, listing conditions and information disclosure requirements.

　　Kelu Electronics: the equipment procurement project of energy storage system won the bid.

　　On July 5th, the financial sector announced that Kelu Electronics had won the bid for the energy storage system equipment procurement project of Ningxia Jingneng Xuanhe 150MW/300MWh energy storage project of China Power Construction Shandong Power Construction Company, and the winning bid amount was about 410 million yuan.

　　Kaizhong shares plan to send 6 yuan 10 shares to pay dividends on July 13th.

　　() Announcement, the company plans to distribute the cash dividend 6.0 yuan (including tax) for every 10 shares in the annual equity distribution in 2021, and the cash dividend distribution date is July 13, 2022.

　　Zhejiang medicine: the subsidiary Xinma Bio plans to increase capital in round B and introduce war investment.

　　Zhejiang Pharmaceutical announced that Xinma Bio, a subsidiary, plans to carry out round B capital increase to introduce ten strategic investors, including Advanced Manufacturing Industry Investment Fund Phase II (Limited Partnership), Li ‘an Xinshao Co., Ltd., Suzhou Lirun Equity Investment Center (Limited Partnership), Runtu Shares, Saizhi Bole, Zhexin Boyuan and Zhexin Ruibo. The investors plan to increase the capital of the target company with a total capital increase of 401.5 million yuan or equivalent US dollars, and subscribe for the new registered capital of the target company. 625,774 yuan (the remaining capital increase is included in the capital reserve of the target company), and the equity of the target company after capital increase is about 12.9454%.

　　China Nuclear Power: The cumulative commercial power generation in the first half of the year increased by 8.15% year-on-year.

　　China Nuclear Power announced on July 5 that as of June 30, 2022, the company’s nuclear power holding 25 units in operation, with an installed capacity of 23.71 million kilowatts; Holding 8 units of the project under construction, with an installed capacity of 8.878 million kilowatts; Holding one approved unit with an installed capacity of 1.251 million kilowatts. In the first half of the year, the company accumulated 94.35 billion kWh of commercial power generation, an increase of 8.15% year-on-year; The online electricity consumption was 89.479 billion kWh, up 9.53% year-on-year.

　　Kelu Electronics: Won the bid for 410 million yuan energy storage system equipment procurement project.

　　Kelu Electronics announced on the evening of July 5 that the company won the bid for the energy storage system equipment procurement project of Ningxia Jingneng Xuanhe 150MW/300MWh energy storage project of China Power Construction Shandong Power Construction Company, with the winning bid amount of about 410 million yuan, accounting for 12.8% of the company’s annual operating income in 2021.

　　Xinyichang will send 5 yuan and date of record for every 10 shares in 2021 as July 11th.

　　() Financial News Xinyichang announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 102,133,600 shares, a cash dividend of RMB 5.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 51,066,800 will be distributed, accounting for 22.01% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Xinyichang, the company’s operating income was 1.197 billion yuan, a year-on-year increase of 69.9%; The net profit attributable to shareholders of listed companies was 232 million yuan, a year-on-year increase of 115.78%; The basic earnings per share was 2.48 yuan, compared with 1.40 yuan in the same period last year.

　　Shenzhen Xinyichang Technology Co., Ltd. is mainly engaged in R&D, production and sales of intelligent manufacturing equipment in LED, capacitor, semiconductor, lithium battery and other industries, providing advanced and stable equipment and solutions for customers to realize intelligent manufacturing. The company’s main products are LED packaging equipment, semiconductor packaging equipment, capacitor aging test equipment and lithium battery equipment.

　　(Source: Straight Flush iFinD)

　　Debon shares: It is planned to sell no more than 1.95% shares of China Eastern Airlines Logistics.

　　() Announced on the evening of July 5th, it is proposed to authorize the general manager of the company to reduce his holdings by no more than 30,957,300 A shares through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Logistics.

　　Debon intends to reduce its holdings of aviation logistics shares by no more than 30,957,300 shareholders.

　　Debon shares announced that the company intends to authorize the general manager of the company to reduce the holdings of A shares of Air Logistics by no more than 30,957,300 shareholders through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics.

　　Debon intends to reduce its holdings of aviation logistics shares by no more than 30,957,300 shareholders.

　　Debon shares announced that the company intends to authorize the general manager of the company to reduce the holdings of A shares of Air Logistics by no more than 30,957,300 shareholders through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics.

　　Debon shares: It is planned to sell no more than 1.95% shares of China Eastern Airlines Logistics.

　　Debon announced on the evening of July 5 that it intends to authorize the general manager of the company to reduce the A shares of Air Logistics by no more than 30,957,300 shareholders through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Logistics.

　　The cumulative reduction ratio of Lan Jian intelligent shareholder Jinan Venture Capital reached 3.04%, and the reduction interval expired.

　　Lan Jian Intelligent announced that on July 5, 2022, the company received the Notice Letter on the Expiration of the Share Reduction Plan and the Reduction Results from the shareholder Jinan Science and Technology Venture Capital Group Co., Ltd. (hereinafter referred to as "Jinan Venture Capital"). As of July 5, 2022, the time interval of the reduction plan expired, and Jinan Venture Capital has reduced its holdings by 2,209,600 shares through centralized bidding and block trading, accounting for 3.04% of the company’s total share capital.

　　Kaizhong shares will send 6 yuan date of record for every 10 shares in 2021 as July 12th.

　　Straight flush financial news Kaizhong shares announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 103,472,400 shares, a cash dividend of RMB 6.00 will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 61,933,500, accounting for 73.54% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Kaizhong, the company’s operating income was 548 million yuan, a year-on-year increase of 10.92%; The net profit attributable to shareholders of listed companies was 84.2177 million yuan, a year-on-year increase of 1.81%; The basic earnings per share was 0.80 yuan, compared with 0.78 yuan in the same period last year.

　　Shanghai Kaizhong Material Technology Co., Ltd. is mainly engaged in the design, research and development, production and sales of damping components, pedal assemblies and rubber tires in suspension systems. The company’s damping components mainly include damping blocks, spring pads, damping supports and dust covers, among which the damping blocks have obvious competitive advantages. The company has continuously won many honors and awards from the government and customers, including the GM Global Excellent Quality Supplier Award for six consecutive years (2014-2019). During the reporting period, the company has passed the IATF16949 quality management system certification of TüV Rheinland and the ISO14001 environmental management system review of China Quality Certification Center, and obtained OHSAS18001 occupational health and safety management system certification.

　　(Source: Straight Flush iFinD)

　　On July 13th, Radio and Television Network will distribute the cash dividend of 0.03 yuan per share in 2021.

　　The radio and television network announced that the company will pay the 2021 annual cash dividend of 0.030 yuan (including tax) per share on July 13, 2022. The date of record of this equity distribution is July 12, 2022, and the ex-dividend date is July 13, 2022.

　　Chenghe Technology holds a total of 4.12% of the shares, and Chuangyuminghui and Chuangyumingchen intend to clear their positions and reduce their holdings.

　　Chenghe Technology announced that Zhuhai Chuangyu Minghui Equity Investment Fund Enterprise (Limited Partnership) ("Chuangyu Minghui") and its concerted action Guangzhou Chuangyu Mingchen Equity Investment Fund Enterprise (Limited Partnership) ("Chuangyu Mingchen"), which holds 4.12% of the company’s total shares, intend to reduce their holdings by no more than 5.5 million shares (about 4.12% of the company’s total share capital).

　　Xinke Materials plans to raise 1.066 billion yuan through non-public offering of shares for the new battery industrial park project.

　　() Announced that the number of shares to be issued by the company in a non-public manner does not exceed 510 million shares (inclusive), all of which are subscribed by Sichuan Rongxin, and the number of shares to be subscribed accounts for 22.07% of the total share capital of the company after the non-public offering. The total amount of funds raised by this non-public offering of shares does not exceed 1.066 billion yuan (inclusive), and the net amount of funds raised after deducting the issuance expenses will be used for the new battery industrial park (2GWh) project. The pricing benchmark date of this non-public offering is the announcement date of the 21st meeting of the 8th Board of Directors of the Company, and the issue price is 2.09 yuan/share. Sichuan Rongxin will become the controlling shareholder of the company, and Santai State-owned Assets Supervision and Administration Office will become the actual controller of the company.

　　The controlling shareholder of Kehua Holdings intends to plan major events and continue to suspend trading from July 6.

　　() Announcement was issued. On July 3, 2022, the company received a notice from Mr. Hung Min Chen, the controlling shareholder of the company. Mr. Hung Min Chen and his concerted actions are planning the transfer of shares of the company, which may lead to changes in the controlling shareholder and actual controller of the company.

　　Upon the company’s application to the Shanghai Stock Exchange, the company’s shares will continue to be suspended from the market opening on the morning of July 6, 2022 (Wednesday), and it is expected that the suspension will last no more than three trading days.

　　Dongpeng Beverage plans to increase its capital by US$ 185 million to its wholly-owned subsidiary, Dongpeng Hong Kong.

　　() Announcement: In order to expand its business capability, the company intends to continue to increase its capital in the form of cash contribution to Dongpeng Beverage (Hong Kong) Co., Ltd. ("Dongpeng Hong Kong"), a wholly-owned subsidiary. The amount of capital to be increased this time is US$ 185 million.

　　Xinke Materials was granted the license of new aluminum-based composite anode and battery technology by Zhongke Ruineng.

　　Xinke Materials announced that it had signed the Technology Licensing Agreement with Shenzhen Zhongke Ruineng Industrial Co., Ltd. ("Zhongke Ruineng"). Zhongke Ruineng awarded the company the license technology such as "New Aluminum-based Composite Anode and Battery Technology" to engage in the production, manufacture and sales of battery products. Zhongke Ruineng appointed a core technical team to teach and train the company’s technicians on the license technology to help the company’s technicians master the technical implementation requirements, and will also provide technical consulting support for the company in project construction, equipment selection, installation and commissioning, and product trial production.

　　It is reported that based on the above-mentioned technical license, the company set up a wholly-owned subsidiary, Sichuan Xinke New Energy Co., Ltd. (tentative name) in Santai County, Mianyang City, Sichuan Province to invest in the construction of a new battery industrial park (2GWh) project to produce new aluminum-based battery cells and PACK products, and build a market leader in sub-applications.

　　Kelu Electronics won the bid for 410 million yuan energy storage system equipment procurement project.

　　Kelu Electronics announced on the evening of July 5th that the company was shortlisted for the energy storage system equipment procurement project of Ningxia Jingneng Xuanhe 150MW/300MWh energy storage project of China Power Construction Shandong Power Construction Company, and the winning bid amount was about 410 million yuan. The company said that this is the first 100 MW independent energy storage project it participated in in in China, and winning the bid in this project has a positive effect on the company’s future energy storage business expansion.

　　Xinke Materials plans to invest 1.089 billion yuan to set up a subsidiary to build a new battery industrial park project.

　　Xinke Materials announced that it plans to set up a wholly-owned subsidiary Sichuan Xinke New Energy Co., Ltd. ("Sichuan Xinke") in Santai County, Mianyang City, Sichuan Province to invest in the construction of a new battery industrial park (2GWh) project with a total investment of 1,089.32 million yuan. This project is a non-public offering of funds by the company. The scale of funds raised is 1,065.9 million yuan, and the remaining funds are raised by the company. The construction period of this project is expected to be 2 years, and investment will be started from the date of receipt of the raised funds. The construction land area of this project is 195 mu.

　　Nanguo Real Estate plans to increase its capital by 350 million yuan to Jinshui Huiye, and its shareholding ratio remains unchanged.

　　() On the evening of July 5th, it was announced that in order to do a good job in the development and construction of Mentougou project and improve the operation efficiency of the project, Wuhan Yuehe Enterprise Management Consulting Co., Ltd. (hereinafter referred to as "Wuhan Yuehe") and Jindi Xingye, a wholly-owned subsidiary of the company, plan to jointly increase the capital of Jinshui Huiye by 700 million yuan, including 350 million yuan from Wuhan Yuehe and 350 million yuan from Jindi Xingye. After the capital increase is completed, the shareholding structure of Jinshui Huiye will remain unchanged. Before and after the capital increase, Wuhan Yuehe and Jindi Xingye each held 50% equity of Jinshui Huiye.

　　According to the announcement, on March 9, 2022, Wuhan Yuehe acquired 50% equity of Beijing Jinshui Huiye Real Estate Development Co., Ltd. (hereinafter referred to as "Jinshui Huiye"), a subsidiary of Jindi Xingye, and Wuhan Yuehe signed a cooperation agreement with Jindi Xingye to jointly develop R2 Class II residential land projects in Yongding Town, Mentougou District, Beijing (hereinafter referred to as "Mentougou" After the capital increase and shareholding, the registered capital of Jinshui Huiye is 100 million yuan, and Wuhan Yuehe and Jindi Xingye each account for 50%.

　　After the completion of this capital increase, the registered capital of Jinshui Huiye will become 800 million yuan.

　　Nanguo Real Estate said that this capital increase to Jinshui Huiye is based on relevant strategic arrangements to enhance the company’s comprehensive development capability and competitiveness. At the same time, it will further deepen cooperation with (), make full use of gemdale’s deep-rooted advantages in Jingxi, and create greater value for the company’s shareholders, which is in line with the company’s need to accelerate the implementation of the national strategic layout.

　　Xinke Materials plans to set up a subsidiary of 30 million yuan to form a large-scale procurement effect.

　　Xinke Materials announced that the company intends to establish a wholly-owned subsidiary Anhui Xinke Metal Materials Co., Ltd. ("Xinke Metal Materials") with a registered capital of RMB 30 million. The business scope covers non-ferrous metals, production auxiliary materials trade, non-ferrous metals import and export trade, logistics, etc.

　　According to this announcement, the company has formed five production bases in Wuhu, Anhui, Wuxi, Jiangsu, Fusui, Guangxi, Tongling, Anhui, and yingtan, Jiangxi, and its decentralized pattern has correspondingly restricted channel control and large-scale procurement. Taking Xinke metal materials as the supply chain integration platform of each production base, the scattered procurement channels are integrated and unified, forming a large-scale procurement effect.

　　Xinke Material: It is planned to raise no more than RMB 1,065.9 million from Sichuan Rongxin Dingsheng.

　　Xinke Materials announced on the evening of July 5 that the company plans to issue no more than 510 million shares to Sichuan Rongxin (accounting for 22.07% of the company’s total share capital after the non-public offering) and raise no more than 1,065.9 million yuan for the 2GWh project of the new battery industrial park. At present, Chuanshan Culture and Sichuan Rongxin, the controlling shareholders of the company, are planning the share transfer, which may lead to the change of the company’s control rights. The share transfer and this non-public offering are carried out at the same time, and they are not prerequisites for each other. Sichuan Rongxin will become the controlling shareholder of the company, and Santai County State-owned Assets Supervision and Administration Office will become the actual controller of the company.

　　Emma Technology plans to invest 1.15 billion yuan to build the Emma Smart Travel Industrial Park project.

　　Emma Technology announced that the company plans to invest in the construction of Emma Smart Travel Industrial Park project in Guigang, with a total planned investment of about 1.15 billion yuan.

　　Kemei Diagnostics shareholders intend to reduce their holdings by no more than 3%.

　　Kemei Diagnostics announced that Ping An Real Estate, a shareholder, and Pingsheng Ankang, a concerted action person, intend to reduce their holdings by no more than 12.03 million shares of the company and no more than 3% of the company’s total share capital.

　　The broadcasting network will pay 0.30 yuan for every 10 shares in 2021, and date of record will be July 12th.

　　Straight Flush Financial News Broadcasting Network announced that the company’s 2021 annual equity distribution implementation plan is as follows: based on the total share capital of 710,503,800 shares, a cash dividend of 0.30 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 21,315,100 yuan will be distributed, accounting for 33.37% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Radio and Television Network, the company’s operating income was 3.005 billion yuan, an increase of 8.88% year-on-year; The net profit attributable to shareholders of listed companies was 63.8712 million yuan, a year-on-year increase of 4.7%; The basic earnings per share was 0.09 yuan, compared with 0.09 yuan in the same period last year.

　　Shaanxi Radio and Television Network Media (Group) Co., Ltd. is a company mainly engaged in radio and television network, radio and television program receiving and transferring, radio and television network information service, consulting, satellite ground receiving, advertising and other services. At present, the company has two excellent technical platforms: "Cable Digital TV Application Technology Laboratory of State Administration of Radio, Film and Television" and "Joint Laboratory of Digital TV Terminal Unified Scheme".

　　As the only listed company in Shaanxi provincial cultural enterprises, Party committees and governments at all levels, especially the Propaganda Department of Shaanxi Provincial Committee of the Communist Party of China, as the actual controller of the company, have given great attention and support to the company’s development. The construction, implementation and business development of projects such as "Media Center" and "Insight Project" won by the company from party committees and governments at all levels provide an opportunity for the company to realize industrial transformation, and also open up space for the company to give full play to its advantages and build a first-class cultural enterprise with core competitiveness.

　　(Source: Straight Flush iFinD)

　　Xinke Materials intends to raise no more than 1.066 billion yuan from Sichuan Rongxin for the new battery industrial park project.

　　Xinke Materials announced that the company plans to issue shares in a non-public manner at a price of 2.09 yuan/share, with the target of Sichuan Rongxin, and the total amount of funds raised will not exceed 1,065,900,000 yuan. After deducting the issuance expenses, the net amount of funds raised will be used for the new battery industrial park (2GWh) project.

　　On June 22, 2022, Sichuan Rongxin and Chuanshan Culture signed the Intention Agreement on Share Transfer, and Chuanshan Culture, the controlling shareholder of the company, intends to transfer its issuer shares to Sichuan Rongxin, which may lead to changes in the company’s control rights. On July 5, 2022, Sichuan Rongxin signed a Conditionally Effective Share Subscription Contract with the company. Sichuan Rongxin intends to subscribe for no more than 510 million shares issued by the company in cash, and the number of shares to be subscribed accounts for 22.07% of the company’s total share capital after the non-public offering. After the issuance, Sichuan Rongxin will become the controlling shareholder of the company, and Santai County State-owned Assets Supervision and Administration Office will become the actual controller of the company.

　　Bette Zhilian: Stock trading fluctuates abnormally.

　　On July 5, 2022, Beit Zhilian announced that the closing price of the company’s shares had fallen by 74.51% in the last three trading days (June 29, 2022-July 5, 2022), which is an abnormal stock trading fluctuation according to the relevant provisions of the Monitoring Rules for Abnormal Stock Trading in the National Small and Medium-sized Enterprise Share Transfer System (Trial).

　　The reason for the fluctuation of this stock transaction is that the buyers and sellers independently trade, and the stock price is self-competitive trading on the platform, which belongs to market behavior.

　　Financial Tips: According to public data, the operating income of Beit Zhilian in 2021 was 10,867,535 yuan, the net profit attributable to the parent company was-765,836 yuan, the return on net assets was -3.43%, and the growth rate of operating income was -5.51%. At present, the sponsoring brokerage firm is () Co., Ltd., and the trading method is call auction trading, which belongs to the basic level.

　　Huaxia Dentsu: Ms. Wu Man, the supervisor, resigned

　　Tongbi AI News, Huaxia Dentsu announced on July 5, 2022 that the board of supervisors of the Company received the resignation report submitted by Ms. Wu Man, the supervisor, on July 4, 2022, and the resignation took effect from the date when the new supervisor was elected at the shareholders’ meeting. The above-mentioned resignees hold 0 shares of the company, accounting for 0% of the company’s share capital. They are not the object of joint punishment for dishonesty and will no longer hold other positions of the company after resigning.

　　Financial Tips: According to public data, the operating income of Huaxia Dentsu in 2021 was 231,392,983 yuan, the net profit attributable to the parent company was 36,477,130 yuan, the return on net assets was 15.04%, and the growth rate of operating income was 49.58%. At present, the sponsored brokerage firm is Southwest Securities Co., Ltd., and the trading method is call auction trading, which belongs to the basic level.

　　Honghe Technology will pay 0.984 yuan for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News Honghe Technology announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 884.37 million shares, a cash dividend of 0.98 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 87.022 million yuan will be distributed, accounting for 70.03% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Honghe Technology, the company’s operating income was 808 million yuan, a year-on-year increase of 30.23%; The net profit attributable to shareholders of listed companies was 124 million yuan, a year-on-year increase of 6.13%; The basic earnings per share was 0.14 yuan, compared with 0.13 yuan in the same period last year.

　　Honghe Electronic Materials Technology Co., Ltd. is mainly engaged in the research, development, production and sales of high-end electronic grade glass fiber cloth. The main products are high-end electronic grade glass fiber cloth series products, mainly including ultra-thin (thickness less than 28μm), ultra-thin (thickness 28-35μm) and thin (thickness 36-100μm) electronic grade glass fiber cloth. In 2010, the company’s electronic grade glass fiber cloth was awarded the certificate of "Shanghai Key New Product" by Shanghai Science and Technology Commission.

　　(Source: Straight Flush iFinD)

　　In 2021, Silanwei sent 1 yuan date of record for every 10 shares on July 12th.

　　Straight Flush Financial News Shi Lanwei announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 1,416,071,800 shares, a cash dividend of RMB 1.00 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 142 million will be distributed, accounting for 9.33% of the net profit returned to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Silanwei, the company’s operating income was 7.194 billion yuan, a year-on-year increase of 68.07%; The net profit attributable to shareholders of listed companies was 1.518 billion yuan, a year-on-year increase of 2,145.25%; The basic earnings per share was 1.13 yuan, compared with 0.05 yuan in the same period last year.

　　The main business of Hangzhou Silan Microelectronics Co., Ltd. is the research and development, production and sales of electronic components. Products mainly include integrated circuits, devices and light emitting diodes. The company was recognized as a "key software and integrated circuit design enterprise within the national planning layout" by the National Development and Reform Commission, the Ministry of Industry and Information Technology and other national ministries and commissions, and successively undertook a number of scientific research special topics of the national major scientific and technological projects "01 Special Project" and "02 Special Project".

　　(Source: Straight Flush iFinD)

　　In 2021, Changdian Technology sent 2 yuan date of record for every 10 shares on July 13th.

　　Straight Flush Financial News () announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 1,779,553,000 shares, a cash dividend of 2.00 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 356 million yuan will be distributed, accounting for 12.03% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 13th, and the ex-dividend date is July 14th.

　　According to the 2021 annual performance report released by Changdian Technology, the company’s operating income was 30.502 billion yuan, a year-on-year increase of 15.26%; The net profit attributable to shareholders of listed companies was 2.959 billion yuan, a year-on-year increase of 126.83%; The basic earnings per share was 1.72 yuan, compared with 0.81 yuan in the same period last year.

　　Jiangsu Changdian Technology Co., Ltd. is the world’s leading provider of integrated circuit manufacturing and technical services, providing all-round one-stop services for finished chip manufacturing, including integrated circuit system integration, design simulation, technology development, product certification, wafer mid-test, wafer-level middle-track packaging test, system-level packaging test and finished chip test, and can provide direct shipping services to semiconductor customers all over the world. According to the list of the top ten global packaging and testing companies in 2020 released by ChipInsights, Changdian Technology ranks third among the top ten OSAT manufacturers in the world with an estimated revenue of 25.563 billion yuan, and Chinese mainland ranks first.

　　(Source: Straight Flush iFinD)

　　Hangzhou Bank will send 3.5 yuan and date of record for every 10 shares in 2021 as July 12th.

　　Straight Flush Financial News () announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 5,930,274,900 shares, a cash dividend of RMB 3.50 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 2.076 billion will be distributed, accounting for 22.41% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Hangzhou Bank, the company’s operating income was 29.361 billion yuan, up 18.36% year-on-year; The net profit attributable to shareholders of listed companies was 9.261 billion yuan, a year-on-year increase of 29.77%; The basic earnings per share was 1.43 yuan, compared with 1.17 yuan in the same period last year.

　　The main business of Hangzhou Bank Co., Ltd. is to provide comprehensive commercial banking products and services for urban and rural small and medium-sized enterprise customers and residents’ families. During the reporting period, the company completed the issuance of five credit asset securitization projects with a total amount of 17.321 billion yuan. Among them, the total amount of ABS issued by public credit ranks 8th among the national commercial banks and 1st among the national city commercial banks, and it won the "Excellent Transaction Award of the Year" and "New Award of the Year" of the 2019 China Asset Securitization Forum Annual Meeting and the "Market Leading Sponsor Award" and "Outstanding Product Award" of the 2019 Fourth China Asset Securitization Industry Huijing Award.

　　(Source: Straight Flush iFinD)

　　Gorgeous family will pay 0.05 yuan for every 10 shares in 2021, and date of record will be July 12th.

　　Straight Flush Financial News () announced that the company’s 2021 annual equity distribution implementation plan is as follows: based on the total share capital of 1,602,290,000 shares, a cash dividend of 0.05 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 8,011,400 yuan will be distributed, accounting for 8.32% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Gorgeous Family, the company’s operating income was 525 million yuan, down 51.39% year-on-year; The net profit attributable to shareholders of listed companies was 96.3068 million yuan, a year-on-year decrease of 35.86%; The basic earnings per share was 0.06 yuan, compared with 0.09 yuan in the same period last year.

　　Gorgeous Family Company Limited is now engaged in real estate development and management. The company’s main products include real estate, architectural decoration, machinery manufacturing and non-metallic mineral products. The company was selected as "Top 50 Outstanding Enterprises in China Urban Construction and Real Estate Scientific Development".

　　(Source: Straight Flush iFinD)

　　Baili Electric will distribute 0.29 yuan for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News Bailey Electric announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 1,087,735,300 shares, a cash dividend of 0.29 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 31,544,300 yuan will be distributed, accounting for 30.12% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Bailey Electric, the company’s operating income was 2.34 billion yuan, a year-on-year increase of 6.38%; The net profit attributable to shareholders of listed companies was 105 million yuan, a year-on-year decrease of 4.78%; The basic earnings per share was 0.10 yuan, compared with 0.10 yuan in the same period last year.

　　Tianjin Bai Park Jung Su Fine Electric Co., Ltd. is an enterprise mainly engaged in power transmission and distribution and control equipment and pumps. The company’s main products include: distribution switch control equipment, SVC, SVG, transformers, terminals, electromagnetic wires, coils, copper bars and pumps.

　　(Source: Straight Flush iFinD)

　　In 2021, GM will transfer 2 shares for every 10 shares and send 0.8 yuan and date of record as July 12th.

　　Straight Flush Financial News General Co., Ltd. announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 1,074,796,700 shares, a cash dividend of 0.80 yuan will be distributed to all shareholders for every 10 shares, with a total cash dividend of 85,983,700 yuan, accounting for 740.57% of the net profit attributable to the mother in the same period, and 2.00 shares will be transferred to all shareholders for every 10 shares with capital reserve fund, and no bonus will be distributed.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by GM, the company’s operating income was 4.256 billion yuan, a year-on-year increase of 23.43%; The net profit attributable to shareholders of listed companies was 11.6104 million yuan, a year-on-year decrease of 87.24%; The basic earnings per share was 0.01 yuan, compared with 0.10 yuan in the same period last year.

　　The main business of Jiangsu General Technology Co., Ltd. is the research and development, production and sales of tire products. The company’s main products are all-steel radial tires, semi-steel radial tires and bias tires, among which all-steel radial tires include short-distance industrial and mining tires, medium and short-distance load-bearing tires, medium and long-distance road transport tires, light truck tires and so on. Semi-steel radial tire products include PCR (family car tire), SUV (city off-road tire), AT/MT (off-road tire), LT (commercial truck tire) and so on.

　　(Source: Straight Flush iFinD)

　　Xiamen Airport will pay 1.43 yuan for every 10 shares in 2021, and date of record will be July 13th.

　　Straight Flush Financial News () announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 297.81 million shares, a cash dividend of RMB 1.43 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 42.5868 million will be distributed, accounting for 30.05% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 13th, and the ex-dividend date is July 14th.

　　According to the 2021 annual performance report released by Xiamen Airport, the company’s operating income was 1.247 billion yuan, a year-on-year increase of 1.79%; The net profit attributable to shareholders of listed companies was 142 million yuan, a year-on-year decrease of 17.31%; The basic earnings per share was 0.48 yuan, compared with 0.58 yuan in the same period last year.

　　The main business of Yuanxiang (Xiamen) International Airlines () Co., Ltd. is air transportation, providing the use guarantee and service of terminal facilities, etc. The company’s main products and services are aviation business, cargo terminal and cargo service, leasing and franchise, and ground handling. The route network layout of Xiamen Airport has been continuously improved. During the reporting period, the passenger throughput ranked 13th in the country, and the overseas passenger throughput ranked 9th in the country, ranking first among airports in Haixi region.

　　(Source: Straight Flush iFinD)

　　Chun Xue Food will send 1 yuan and date of record for every 10 shares in 2021 on July 11th.

　　Straight Flush Financial News () issued an announcement, and the contents of the company’s annual equity distribution implementation plan in 2021 are as follows: based on the total share capital of 200 million shares, a cash dividend of RMB 1.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 20 million will be distributed, accounting for 35.35% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Chun Xue Food, the company’s operating income was 2.033 billion yuan, a year-on-year increase of 9.15%; The net profit attributable to shareholders of listed companies was 56.5814 million yuan, a year-on-year decrease of 61.88%; The basic earnings per share was 0.35 yuan, compared with 0.99 yuan in the same period last year.

　　The main business of Chun Xue Food Group Co., Ltd. is specialized in the research, development, production, processing and sales of white feather chicken meat food. The company’s main products are chicken conditioning products and fresh products. The company has passed series of certifications such as ISO9001, ISO22000, ISO45001, ISO14001, HACCP, EU GAP, EU BRC, green food, etc., and has been recognized by CNAS National Laboratory, and has been recognized as one of the first batch of 24 "three-in-one" demonstration enterprises for exporting food in China. Our products have been exported to Japan and the European Union for many years, and we have a number of well-known customers at home and abroad with high viscosity, such as Itochu Corporation, Dicos Fast Food, () Supermarket, familymart and Cargill Animal Protein.

　　(Source: Straight Flush iFinD)

　　Fengzhu Textile will pay 0.808 yuan for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News Fengzhu Textile announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 272 million shares, a cash dividend of 0.81 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 21,977,600 yuan will be distributed, accounting for 30.03% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Fengzhu Textile, the company’s operating income was 1.302 billion yuan, a year-on-year increase of 24.03%; The net profit attributable to shareholders of listed companies was 73.1947 million yuan, a year-on-year increase of 147.05%; The basic earnings per share was 0.27 yuan, compared with 0.11 yuan in the same period last year.

　　Fujian Fengzhu Textile Technology Co., Ltd. is mainly engaged in the production, processing and knitting, woven colored cloth, bleaching and dyeing, spinning, yarn dyeing and printing, and selling self-produced products; Engaged in the operation of environmental protection facilities; Engaged in the import and export business of goods or technologies, etc. The main products are knitted grey fabric, knitted finished fabric and package colored yarn. The developed products "hemp mesh cloth" and "harvest season" won "2019 China International Fabric Design Competition and 2020 Spring/Summer Fashion Fabric Excellence Award"; The developed product "Emerald Star" won the second prize of "2019 China Excellent Printing and Dyeing Fabric"; "Fish Scale Ripples" won the first prize of "2019 China Excellent Printing and Dyeing Fabric". At present, the company’s water, electricity, steam, sewage treatment and other infrastructure facilities are complete, the production equipment has reached the advanced level of the world counterparts, and a relatively complete technological innovation system and industrial chain have been formed. It has been selected as one of the "Top 500 Competitive Enterprises of China Textile and Apparel Enterprises" and "Top 10 Competitive Enterprises of China Knitting Industry" for many years.

　　(Source: Straight Flush iFinD)

　　Xinhuanet will pay 1.63 yuan for every 10 shares in 2021, and date of record will be July 12th.

　　Straight Flush Financial News () announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 519,029,400 shares, a cash dividend of RMB 1.63 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 84,601,800 will be distributed, accounting for 40.19% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Xinhuanet, the company’s operating income was 1.724 billion yuan, a year-on-year increase of 20.28%; The net profit attributable to shareholders of listed companies was 211 million yuan, a year-on-year increase of 27.63%; The basic earnings per share was 0.41 yuan, compared with 0.32 yuan in the same period last year.

　　Xinhuanet Co., Ltd. is mainly engaged in online advertising, information services, website construction and technical services and mobile Internet services. The company’s main products and services include online advertising display and release, multimedia message service, big data intelligent analysis services, holding forums, conference activities, website construction of central government and local governments, enterprises and institutions, information release, operation and maintenance, mobile media business, mobile value-added business, mobile information business and online education business. Xinhuanet is a comprehensive news information service portal hosted by Xinhua, a national news agency. It is one of the most influential online media in China and a Chinese website with global influence. Xinhuanet has brand columns such as "Learning in Progress", "Data News", "Thinking", "Xinhua Online Review" and "Xinhua Interview", and has built government websites such as China Government Network, China Civilization Network, China Emergency Information Network, China Xiong ‘an official website, China Internet Joint Refutation Platform, and operated the largest government website cluster in China and government WeChat WeChat official account. In the 29th China News Awards, five more works won awards, and the total number of awards remained the first in the central key news websites. Alexa international comprehensive ranking ranks in the top 40.

　　(Source: Straight Flush iFinD)

　　0.5 yuan and date of record will be sent to New Huangpu for every 10 shares in 2021 as July 12th.

　　Straight Flush Financial News New Huangpu announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 673,396,800 shares, a cash dividend of 0.50 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 33,669,800 yuan will be distributed, accounting for 30.62% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by New Huangpu, the company’s operating income was 3.942 billion yuan, a year-on-year increase of 195.85%; The net profit attributable to shareholders of listed companies was 110 million yuan, a year-on-year decrease of 59.1%; The basic earnings per share was 0.16 yuan, compared with 0.40 yuan in the same period last year.

　　The main business of Shanghai New Huangpu Industrial Group Co., Ltd. is real estate development and sales, and its business model is mainly independent development, sales and rental. The company’s business sector is divided into commercial office real estate development, residential real estate development and park construction and development. At present, the business scope of the company’s real estate development is mainly concentrated in Shanghai, Zhejiang and Jiangsu. The main products of the company’s real estate development business are high-end office buildings, ordinary commercial houses, serviced apartments, science and technology parks, affordable houses, long-term rental houses, multi-storey houses and villas.

　　(Source: Straight Flush iFinD)

　　Jiuzhou Pharmaceutical will send 2.5 yuan date of record for every 10 shares in 2021 as July 12th.

　　Straight Flush Financial News Jiuzhou Pharmaceutical announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 834,300,700 shares, a cash dividend of RMB 2.50 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 209 million will be distributed, accounting for 32.9% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Jiuzhou Pharmaceutical, the company’s operating income was 4.063 billion yuan, a year-on-year increase of 53.48%; The net profit attributable to shareholders of listed companies was 634 million yuan, a year-on-year increase of 66.56%; The basic earnings per share was 0.77 yuan, compared with 0.47 yuan in the same period last year.

　　Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is mainly committed to providing CDMO one-stop service for innovative drug companies and new drug research and development institutions at home and abroad in research and development and production of innovative drugs; At the same time, it provides business of technological innovation and commercial production for global chemical raw materials and pharmaceutical intermediates. The company’s products cover central nervous system, non-steroidal anti-inflammatory, hypoglycemic and anti-infective drugs, such as carbamazepine, oxcarbazepine, penem, ketoprofen, gliclazide and sulfonamides. The company has successively passed the official drug administration inspections in China NMPA (National Medical Products Administration, China), US FDA (American Food and Drug Administration), EU EDQM (European Drug Quality Administration), Japan PMDA (Japanese Drug Administration), Italy AIFA (Italian Drug Administration), Mexico COFEPRIS (Mexican Ministry of Health) and Brazil ANVISA (Brazilian Health Supervision Administration).

　　(Source: Straight Flush iFinD)

　　Newway shares will send 2.5 yuan date of record for every 10 shares in 2021 as July 13th.

　　Straight Flush Financial News Newway shares announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 749.062 million shares, a cash dividend of RMB 2.50 will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 187 million, accounting for 49.61% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 13th, and the ex-dividend date is July 14th.

　　According to the 2021 annual performance report released by Newway, the company’s operating income was 3.962 billion yuan, a year-on-year increase of 9.07%; The net profit attributable to shareholders of listed companies was 377 million yuan, a year-on-year decrease of 28.46%; The basic earnings per share was 0.50 yuan, compared with 0.70 yuan in the same period last year.

　　The main business of Suzhou Newway Valve Co., Ltd. is to design and manufacture industrial valves and pipeline control equipment, self-propelled oil extraction machinery and parts, sell self-produced products and provide relevant after-sales services, and is entrusted to process valve series products and parts. At present, the main products are gate valves, globe valves, check valves, ball valves, butterfly valves, regulating valves, API6A valves, underwater valves, safety valves and nuclear power valves. Over the years, the company has devoted itself to the independent innovation and development of valve product technology, introduced advanced simulation technology and R&D design management system, and has built a world-class valve material laboratory and engineering laboratory, equipped with world-class experimental equipment, and developed a series of high-tech valve products, which are widely used in oil and gas exploitation and transportation, refining and chemical industry, marine engineering, coal chemical industry, air separation, nuclear power, electric power, mining and other fields.

　　(Source: Straight Flush iFinD)

　　Talents in Central China: Wuhan Kewo Human Resources Co., Ltd., a wholly-owned subsidiary, is to be established with a registered capital of 2 million.

　　Tongbi AI News, Huazhong Talent announced on July 5, 2022 that in order to further optimize the company’s strategic layout and better develop the service market, Wuhan Huazhong New Century Talent Co., Ltd. (hereinafter referred to as "the company") plans to set up Wuhan Kewo Human Resources Co., Ltd. (tentatively named, subject to the final industrial and commercial registration), a wholly-owned subsidiary, with the registered place of China Chegu Human Resources Service Industrial Park, Building A1, Huazhong Zhigu Phase II, No.1 Furong, Wuhan Economic Development Zone, with the registered capital of RMB 2000.

　　(A) the purpose of this foreign investment

　　In order to enhance the company’s sustainable operation ability, meet the needs of business expansion and strategic development, and create new business growth points for the company.

　　(B) The possible risks of this foreign investment

　　This investment is made from the perspective of the company’s future development strategy, aiming to further enrich the service content on the basis of the original business, and there are no other risks.

　　(III) The impact of this foreign investment on the company’s future financial position and operating results

　　This investment is conducive to the improvement of the company’s overall performance and has a positive impact on the company’s future financial situation and operating results.

　　Financial Tips: According to public data, the operating income of Huazhong talents in 2021 was 320,385,592 yuan, the net profit attributable to the parent company was 8,509,135 yuan, the return on net assets was 27.14%, and the growth rate of operating income was 33.31%. At present, the sponsoring brokerage firm is Industrial Securities Co., Ltd., and the trading method is call auction trading, which belongs to the basic level.

　　Zhiyuan Internet: It is planned to buy back the shares of the company from RMB 50 million to RMB 100 million.

　　Zhiyuan Internet announced on the evening of July 5 that it plans to buy back the company’s shares at a price of 50 million to 100 million yuan, and the repurchase price does not exceed 70.51 yuan/share. All the repurchased shares will be used to implement the equity incentive plan at an appropriate time in the future, and will be transferred within three years after the implementation result of share repurchase and the announcement of share change.

　　Yili Jieneng’s controlling shareholder Yili Group passively reduced its holdings by 3,056,900 shares.

　　() Announcement, the company learned from Yili Group that the applicant for judicial enforcement of the above matters is Beijing No.3 Intermediate People’s Court, and has not received other relevant judicial documents. Due to poor communication, its 3,056,907 shares held by the company without pledge were judicially reduced by centralized bidding on June 30, 2022.

　　Debon shares: It is planned to reduce the shareholding of China Eastern Airlines Logistics by no more than 1.95%.

　　China Securities Network News (Reporter Wang Ke) Debon announced on the evening of July 5 that the company intends to authorize the general manager of the company to reduce the holding of A-share shares of China Eastern Airlines Logistics by centralized bidding and block trading, accounting for no more than 30.9573 million shareholders, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics. The proposed shareholding reduction of the company is only the initial intention of the company, the counterparty has not yet been determined, and there is no clear transaction price. Whether the transaction can be completed, the specific transaction time and transaction price are uncertain.

　　Debon shares: It is planned to reduce the shareholding of China Eastern Airlines Logistics by no more than 1.95%.

　　China Securities Network News (Reporter Wang Ke) Debon announced on the evening of July 5 that the company intends to authorize the general manager of the company to reduce the holding of A-share shares of China Eastern Airlines Logistics by centralized bidding and block trading, accounting for no more than 30.9573 million shareholders, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics. The proposed shareholding reduction of the company is only the initial intention of the company, the counterparty has not yet been determined, and there is no clear transaction price. Whether the transaction can be completed, the specific transaction time and transaction price are uncertain.

　　() 1.5118 yuan will be distributed for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News Zhongmu shares announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 1,021,148,300 shares, a cash dividend of 1.51 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 154 million yuan will be distributed, accounting for 30.04% of the net profit returned to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Zhongmu, the company’s operating income was 5.302 billion yuan, a year-on-year increase of 6.06%; The net profit attributable to shareholders of listed companies was 514 million yuan, a year-on-year increase of 22.22%; The basic earnings per share was 0.51 yuan, compared with 0.41 yuan in the same period last year.

　　Zhongmu Industrial Co., Ltd. is mainly engaged in research and development, production, sales and technical services of animal health products and animal nutrition products. The company’s main business includes biological products, veterinary chemicals, feed and feed additives, and trade. The main products are vaccines for livestock, vaccines for poultry, veterinary chemicals, feed and feed additives. The company has the qualifications of National Enterprise Technology Center, Beijing Engineering Technology Research Center, Key Laboratory of Veterinary Biological Products and Chemicals of the Ministry of Agriculture, postdoctoral workstation and CNAS. The company once again won the title of "National Product and Service Quality Integrity Unit in 2019", and its veterinary vaccines, feeds and chemical products won the title of "National Quality Inspection Stable Qualified Products in 2019".

　　(Source: Straight Flush iFinD)

　　Haohua Technology will distribute 2.911 yuan for every 10 shares in 2021, and date of record will be July 12th.

　　Straight Flush Financial News Haohua Technology announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 918,924,700 shares, a cash dividend of 2.91 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 267 million yuan will be distributed, accounting for 30.01% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th.

　　According to the 2021 annual performance report released by Haohua Technology, the company’s operating income was 7.424 billion yuan, a year-on-year increase of 36.92%; The net profit attributable to shareholders of listed companies was 891 million yuan, a year-on-year increase of 37.61%; The basic earnings per share was 0.99 yuan, compared with 0.72 yuan in the same period last year.

　　Haohua Chemical Technology Group Co., Ltd. is mainly engaged in the research, production and sales of catalysts, pressure swing adsorption gas separation technologies and devices, special gases, organic chemical products, special valves and adsorbents, and the development, design and technical consultation of chemical products. The main products are fluorine materials, special gases, special rubber and plastic products, fine chemicals, engineering consulting and technical services. The company has a high market recognition and leading position in the field of special rubber and plastic products. In the field of technical services, the company’s pressure swing adsorption gas separation technology (PSA) has obvious advantages and is one of the three largest PSA technology service providers in the world.

　　(Source: Straight Flush iFinD)

　　State Grid ICT will send 1.7 yuan date of record for every 10 shares in 2021 as July 13th.

　　Straight Flush Financial News State Grid Xintong announced that the company’s 2021 annual equity distribution implementation plan is as follows: based on the total share capital of 1,195,394,500 shares, a cash dividend of RMB 1.70 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 203 million will be distributed, accounting for 30.01% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 13th, and the ex-dividend date is July 14th.

　　According to the 2021 annual performance report released by State Grid ICT, the company’s operating income was 7.466 billion yuan, a year-on-year increase of 6.49%; The net profit attributable to shareholders of listed companies was 677 million yuan, a year-on-year increase of 11.57%; The basic earnings per share was 0.57 yuan, compared with 0.52 yuan in the same period last year.

　　The main business of State Grid Information Communication Co., Ltd. is cloud network infrastructure, cloud platform, cloud application and related enterprise operation support services. The specific business is cloud network infrastructure, cloud platform, cloud application and related enterprise operation support services.

　　(Source: Straight Flush iFinD)

　　Zhiyuan Internet plans to buy back 50 million to 100 million yuan, and the repurchase price does not exceed 70.51 yuan/share.

　　Zhiyuan Internet announced that the company intends to buy back shares, which will all be used to implement the equity incentive plan at a suitable time in the future. The total amount of repurchase funds is not less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive), and the repurchase price is not more than RMB 70.51/share (inclusive).

　　Debon intends to reduce its shareholding in China Eastern Airlines Logistics by no more than 1.95%.

　　Debon shares announced that the company intends to authorize the general manager of the company to reduce his holdings by no more than 30,957,333 A shares of China Eastern Airlines Logistics Co., Ltd. (hereinafter referred to as "China Eastern Airlines Logistics") through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics. At present, the company holds 4.50% shares of China Eastern Airlines Logistics.

　　Debon intends to reduce its shareholding in China Eastern Airlines Logistics by no more than 1.95%.

　　Debon shares announced that the company intends to authorize the general manager of the company to reduce his holdings by no more than 30,957,333 A shares of China Eastern Airlines Logistics Co., Ltd. (hereinafter referred to as "China Eastern Airlines Logistics") through centralized bidding and block trading, accounting for no more than 1.95% of the total share capital of China Eastern Airlines Logistics. At present, the company holds 4.50% shares of China Eastern Airlines Logistics.

　　Shareholders of Chenghe Technology intend to reduce their holdings by no more than 4.12% in total.

　　Chenghe Technology announced that Chuangyuminghui and Chuangyumingchen, shareholders holding a total of 4.12%, plan to reduce the total number of shares of the company by no more than 5.5 million shares, accounting for about 4.12% of the company’s total share capital.

　　Kehua Holdings: The controlling shareholder continued to suspend trading on the transfer of shares of the company.

　　The financial sector reported on July 5 that Kehua Holdings announced that the controlling shareholder Chen Hongminsheng and his concerted actions are planning the transfer of the company’s shares, which may lead to changes in the controlling shareholder and actual controller of the company, and the stock will continue to be suspended. It is expected that the suspension will not exceed three trading days.

　　Shao Dong Gongying, a shareholder of Li Yuan Heng, intends to reduce his shareholding by no more than 0.97%.

　　Li Yuan Heng announced that due to the capital needs of shareholders, Shao Dong Gongying intends to reduce the total number of shares of the company by centralized bidding, which will not exceed 853,600 shares, that is, it will not exceed 0.9700% of the total number of shares of the company. It will be carried out within three months after the disclosure of this reduction plan for three trading days, and the total number of shares reduced in any 90 consecutive natural days will not exceed 1% of the total number of shares of the company.

　　Chihong Zinc Germanium’s performance in the first half of the year increased by 67.45%-75.82%, and its main business improved steadily.

　　() On the evening of July 5th, it was announced that the net profit attributable to the owners of the parent company would be 1,000,000,000 yuan to 1,050,000 yuan in the first half of 2022, an increase of 402.8 million yuan to 452.8 million yuan compared with the same period of last year, with a year-on-year increase of 67.45% to 75.82%.

　　The company said that in the first half of 2022, the market price of zinc, the company’s main product, continued to rise and fluctuated at a high level. The company seized good market opportunities, focused on improving quality and reducing costs, and deepened the benchmarking of all factors. By strengthening comprehensive recycling, reducing financial expenses and upgrading indicators, the main business of zinc, lead and germanium was steadily improved, and its net profit increased significantly compared with the same period of last year. (Gao Yi)

　　Zhiyuan Internet plans to buy back shares from 50 million yuan to 100 million yuan.

　　Zhiyuan Internet announced that the company intends to buy back shares by centralized bidding, and the repurchase amount is not less than 50 million yuan and not more than 100 million yuan; The repurchase price does not exceed 70.51 yuan/share. All the repurchased shares will be used to implement the equity incentive plan.

　　Jiuzhou Pharmaceutical will send 2.5 yuan date of record for every 10 shares on July 12th.

　　Jiuzhou Pharmaceutical announced on the evening of July 5th that the implementation plan of the company’s equity distribution in 2021 is as follows: based on the total share capital of 834,300,700 shares, a cash dividend of RMB 2.50 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 209 million will be distributed, accounting for 32.9% of the net profit attributable to the mother in the same period. No bonus shares will be distributed and no capital reserve will be converted into share capital. The distribution of rights and interests in date of record is July 12th, and the ex-dividend date is July 13th. (Xu Yu)

　　Haizheng Dynamic Insurance, a subsidiary of Haizheng Pharmaceutical, completed capital increase and share expansion and partial equity transfer.

　　Haizheng Pharmaceutical issued an announcement on the evening of July 5. On July 5, the company received the Notice of Transaction Result and the Notice of Capital Increase Result issued by Taizhou Property Rights Exchange Co., Ltd. (Taiwan Stock Exchange), confirming that Wuxi Chenyi Chengyu Consulting Management Partnership and Xiamen Defu Zhongteng Investment Partnership (Limited Partnership) were jointly delisted, and the registered capital of Haizheng Dynamic Insurance held by Haizheng Pharmaceutical was 30.227273 million yuan, with a transaction price of 190 million yuan. The subscription of Haizheng Animal Health Insurance increased the registered capital by 47,727,273 yuan, and the transaction price of capital increase was 300 million yuan, and the equity transfer contract of Zhejiang Haizheng Animal Health Products Co., Ltd. and the capital increase agreement of Zhejiang Haizheng Animal Health Products Co., Ltd. were signed with the company and Haizheng Animal Health Insurance.

　　The announcement shows that on April 25, 2022, the company agreed to implement capital increase and share expansion and transfer of some old shares to Zhejiang Haizheng Animal Health Products Co., Ltd., a holding subsidiary. This capital increase and share expansion and the transfer of old shares are based on the pre-investment valuation of not less than 2.2 billion yuan, and the planned capital increase is not more than 47,727,273 yuan of registered capital, with a total capital increase of 300 million yuan; The transfer of old shares does not exceed 30,227,273 yuan of registered capital, and the total transfer price is 190 million yuan. The transaction was conducted in the form of public listing, and the reserve price of listing was not less than 6.2857 yuan/share. On April 30, 2022, the company and Haizheng Dynamic Insurance submitted a listing application for Haizheng Dynamic Insurance to increase capital and transfer some old shares to the Taiwan Stock Exchange, and entrusted the Taiwan Stock Exchange to increase capital and transfer some old shares through public listing.

　　According to the announcement, Haizheng Pharmaceutical still holds 70.343% of the shares of Haizheng Dynamic Insurance after the completion of the capital increase and share expansion and the transfer of old shares, and remains its controlling shareholder, continuing to merge Haizheng Dynamic Insurance statements. Therefore, the implementation of this plan will not adversely affect the main business of Haizheng Pharmaceutical. (Xu Yu)

　　The Postal Savings Bank will distribute 2.474 yuan for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News () announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 72,527,800,600 shares, a cash dividend of RMB 2.47 million will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 17.943 billion, accounting for 23.56% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by the Postal Savings Bank, the company’s operating income was 318.762 billion yuan, an increase of 11.38% year-on-year; The net profit attributable to shareholders of listed companies was 76.17 billion yuan, up 18.65% year-on-year; The basic earnings per share was 0.78 yuan, compared with 0.71 yuan in the same period last year.

　　Postal Savings Bank of China Limited is mainly engaged in providing banking and related financial services. The main products are personal banking, corporate banking and treasury business.

　　(Source: Straight Flush iFinD)

　　Bank of Communications will distribute 3.55 yuan for every 10 shares in 2021, and date of record will be July 11th.

　　Straight Flush Financial News Bank of Communications announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 39,250,864,000 shares, a cash dividend of 3.55 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 13.934 billion yuan will be distributed, accounting for 15.91% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 11th, and the ex-dividend date is July 12th.

　　According to the 2021 annual performance report released by Bank of Communications, the company’s operating income was 269.39 billion yuan, a year-on-year increase of 9.42%; The net profit attributable to shareholders of listed companies was 87.581 billion yuan, a year-on-year increase of 11.89%; The basic earnings per share was 1.10 yuan, compared with 0.99 yuan in the same period last year.

　　The main business of Bank of Communications Co., Ltd. is to provide banking and related financial services. It is one of the major financial service providers in China, covering commercial banks, securities, trusts, financial leasing, fund management, insurance, offshore financial services, etc. Its wholly-owned subsidiaries include Bank of Communications International Holdings Limited, China Bank of Communications Insurance Co., Ltd. and Bank of Communications Financial Leasing Co., Ltd., Holding subsidiaries include Bank of Communications Schroeder Fund Management Co., Ltd., Bank of Communications International Trust Co., Ltd., Bank of Communications Kanglian Life Insurance Co., Ltd., Dayi Bank of Communications Xingmin Village Bank, Zhejiang Anji Bank of Communications Village Bank, Xinjiang Shihezi Bank of Communications Village Bank, Qingdao Laoshan Bank of Communications Village Bank, in addition to being the largest shareholder of Jiangsu Changshu Rural Commercial Bank Co., Ltd. and the largest shareholder of Tibet Bank Co., Ltd.

　　(Source: Straight Flush iFinD)

　　Dongpeng Beverage plans to increase its capital in Dongpeng, Hong Kong with US$ 185 million.

　　(Reporter Wang Xiao) On July 5, Dongpeng Beverage announced that the company intends to continue to increase the capital of Dongpeng Beverage (Hong Kong) Co., Ltd. (hereinafter referred to as "Hong Kong Dongpeng") in the form of cash contribution, and the proposed capital increase this time is 185 million US dollars. After the completion of this capital increase, the registered capital of Hong Kong Dongpeng will increase to 190 million US dollars.

　　Haoyuan Pharmaceutical shareholder Zhenjin Investment reduced its shareholding by 1.25%.

　　Haoyuan Pharmaceutical announced that on July 4, 2022, the company received the Notice Letter on the Progress of Share Reduction from the shareholder Zhenjin Investment. From June 23, 2022 to July 4, 2022, Zhenjin Investment reduced its holdings of 1.3 million shares through block trading, accounting for 12,491% of the company’s total share capital.

　　Jing Jia, shareholder of Haoyuan Pharmaceutical, reduced its holdings by 790,000 shares.

　　Haoyuan Pharmaceutical announced that on July 4, 2022, the company received the Report on the Change of Simple Equity of Haoyuan Pharmaceutical jointly sent by Jingjia Venture, Shanghai Taili and Hantai Venture, which held more than 5% of the shares. From June 29, 2022 to July 1, 2022, Jingjia Venture reduced its holdings by a total of 790,000 shares, accounting for 0.7590% of the company’s total share capital.

　　Daotong Technology will issue 1.28 billion yuan convertible bonds to lay out the automobile aftermarket under the trend of new energy.

　　On the evening of July 5, Daotong Technology announced that the company’s issuance of convertible bonds of no more than 1.28 billion yuan (inclusive) to unspecified objects has been approved by the CSRC for registration. The term of this convertible bond issue is from July 8, 2022 to July 7, 2028. The raised funds will be used for the construction of Daotong Science and Technology R&D Center and the R&D project of new generation intelligent maintenance and new energy comprehensive solution (hereinafter referred to as "new generation intelligent maintenance and new energy comprehensive solution"), the acquisition of 100% equity of Rainbow Technology, the R&D project of new generation intelligent maintenance and new energy comprehensive solution, and the replenishment of working capital.

　　Among them, the implementation of a new generation of intelligent maintenance and new energy comprehensive solutions will help Daotong Technology to upgrade and develop comprehensive diagnostic products, meet the market demand for intelligent products, fill the market gap through the research and development of new energy tools, highlight the company’s technical level and product advantages, and bring opportunities for the company’s comprehensive business growth.

　　Daotong Technology was established in 2004 and landed in Science and Technology Innovation Edition in February 2020. It is a professional provider of comprehensive solutions for intelligent charging of new energy vehicles, intelligent diagnosis and detection of automobiles, TPMS (tire pressure monitoring system), ADAS (advanced driver assistance system) products and related software cloud services.

　　In recent years, the development of new energy vehicles has been strong, the global penetration rate and ownership of new energy vehicles have been continuously improved, the professional back-end service market has expanded rapidly, and the supporting demand for charging infrastructure, related maintenance services and professional technology has been increasing. Daotong Technology actively lays out new opportunities in the automotive aftermarket in terms of maintenance, maintenance, charging and energy storage under the trend of new energy.

　　According to Daotong Technology, the company takes smart battery detection technology and vehicle-pile compatibility technology as the core, deeply applies the technical capabilities of AI and big data cloud platform, and runs through new energy diagnosis and detection system products, smart charging detection system products, charging operation platform system products and energy storage series products around the whole link of diagnosis, inspection, charging and storage, realizing intelligent and efficient linkage of pile, cloud and energy storage equipment, and continuously building an integrated service of "diagnosis, inspection, charging and storage".

　　Yaopi Glass will pay 0.35 yuan for every 10 shares in 2021, and date of record will be July 13th.

　　Straight Flush Financial News () announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 934,916,100 shares, a cash dividend of 0.35 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 32,722,100 yuan will be distributed, accounting for 30.66% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 13th, and the ex-dividend date is July 14th.

　　According to the 2021 annual performance report released by Yaopi Glass, the company’s operating income was 4.649 billion yuan, a year-on-year increase of 13.82%; The net profit attributable to shareholders of listed companies was 107 million yuan, a year-on-year decrease of 40.47%; The basic earnings per share was 0.11 yuan, compared with 0.19 yuan in the same period last year.

　　Shanghai Yaopi Glass Group Co., Ltd. is a company engaged in glass manufacturing and processing, and its main products are float glass, processed glass and automobile glass. Among them, Yaopi aviation glass was rated as a new product with international advanced level by the glass industry and recommended for the National Science and Technology Progress Award. The economic and social benefits of aviation glass were recognized by all parties.

　　(Source: Straight Flush iFinD)

　　China Railway Construction will pay 2.46 yuan for every 10 shares in 2021, and date of record will be July 25th.

　　Straight Flush Financial News () announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 115,032,455,500 shares, a cash dividend of RMB 2.46 billion will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 2.830 billion, accounting for 11.46% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is July 25th, and the ex-dividend date is July 26th.

　　According to the 2021 annual performance report released by China Railway Construction, the company’s operating income was 1.02 trillion yuan, a year-on-year increase of 12.05%; The net profit attributable to shareholders of listed companies was 24.691 billion yuan, a year-on-year increase of 10.26%; The basic earnings per share was 1.60 yuan, compared with 1.50 yuan in the same period last year.

　　The main business of China Railway Construction Co., Ltd. is project contracting, survey and design consulting, industrial manufacturing, real estate development, logistics and material trade. The company has a complete industrial chain of scientific research, planning, survey, design, construction, supervision, maintenance, operation, investment and financing, and has the ability to provide one-stop comprehensive services for owners. It has established a leading position in the field of plateau railway, high-speed railway, expressway, bridge, tunnel and urban rail transit engineering design and construction.

　　(Source: Straight Flush iFinD)

　　Metro Development plans to sell Shanghai Xingyi Cinema Company.

　　Metro Development (01030) announced that the company and its subsidiary Changzhou Hengxuan Consulting Management Co., Ltd. signed a memorandum of understanding with the potential buyer () Co., Ltd. on July 5, 2022, regarding the potential sale of the equity of Shanghai Xingyi Cinema Management Co., Ltd. The parties agree that the consideration for acquiring 100% equity of the target company will not be less than RMB 3 billion.

　　Yaopi Glass sent 0.035 yuan per share to date of record on July 13th.

　　Yaopi Glass announced that the company will implement the annual equity distribution in 2021, with a cash dividend of 0.035 yuan (including tax) per share, with date of record on July 13th.

　　Aojie Technology’s 1.999 million restricted shares will be listed and circulated on July 14th.

　　Aojie Technology announced that the company lifted the restriction on sales and applied for listing and circulation of 1.999 million shares. Now the lock-up period is about to expire and it will be listed and circulated on July 14, 2022.

　　Cowin China Growth Fund I, L.P, the shareholder of Aojing Medical, reduced its shareholding to less than 5%.

　　Aojing Medical announced that on July 5, the company received a letter of notification from Cowin China Growth Fund I, L.P (the first-phase partnership of Tongchuang China Growth Fund), which reduced its shares by a total of 1.323 million shares through block trading from May 23 to May 30, 2022, accounting for 0.9922% of the company’s total share capital. During the period from July 1 to July 4, 2022, the company reduced its holdings of 120,000 shares by centralized bidding, accounting for 0.09% of the company’s total share capital. After this equity change, its shareholding ratio decreased from 5.5678% to 4.4856%.

　　Zheshang Securities: "Zhejiang 22 Convertible Bonds" will be listed and traded on July 8.

　　() It is announced that the company’s publicly issued 7 billion yuan convertible corporate bonds will be listed and traded on the Shanghai Stock Exchange from July 8, 2022. The bonds are referred to as "Zhejiang 22 Convertible Bonds" and the bond code is "113060".

　　Hengdian Film and Television intends to jointly acquire 100% equity of Shanghai Xingyi with a third party, and the transaction price is expected to be no less than 3 billion yuan.

　　Hengdian Film and Television announced that the company and its related parties intend to join a third party to acquire 100% equity of the target company Shanghai Xingyi by paying cash. On July 5, 2022, the company signed the Agreement of Intention for Acquisition with Shanghai Xingyi, Changzhou Hengxuan Consulting Management Co., Ltd. and their indirect controlling shareholder Xincheng Development Holdings Co., Ltd. It is expected that the actual performance of this transaction may constitute a major asset restructuring. The transaction price of all the shares of the target company is expected to be no less than 3 billion yuan. The target company is mainly engaged in cinema investment management. By December 31st, 2021, there were 128 cinemas under its control.

　　Shanghai Stock Exchange: Approved the application for long-term lithium refinancing.

　　On the evening of July 5th, the Shanghai Stock Exchange announced the results of the 56th review meeting of science and technology innovation board Shanghai Municipal Committee in 2022, and the application for long-term lithium refinancing of listed companies in science and technology innovation board was approved by the Shanghai Stock Exchange. It is reported that the long-term refinancing method of Lithium Branch is public issuance of convertible bonds, and the proposed financing amount is 3.25 billion yuan.

During the Anti-Japanese War, Japanese germ warfare poisoned Jiangnan.

Xinhua News Agency reporters Feng Yuan, Xu Shunda, Gu Xiaoli and Hua Hongli

When it comes to the 731st unit of the Japanese invaders (referred to as the 731st unit), people will think of the evil deeds committed by this "demon unit" in the northeast of China.

During the period of War of Resistance against Japanese Aggression, Unit 731 and its associates also committed countless crimes in Zhejiang and other places.

unexpected calamity

Hu Xianzhong, a citizen of Ningbo, is 89 years old. He still can’t forget the scene of his family’s tragic death in unexpected trouble 81 years ago. In November 1940, his sister, brother, father and mother died of plague in 10 days.

The culprit is the Japanese bacterial weapon. The book "Special Study of Japanese Bacteriological Warfare in Zhejiang" published in 2015 by committee of cpc zhejiang provincial committee Party History Research Office records that on the afternoon of October 27th, 1940, a Japanese plane dropped wheat and millet over Kaiming Street.

"It rained that day, and all the wheat and millet that had fallen on the roof rushed into the water tank where the people received the rain." Hu xianzhong said.

A few days later, the owner of the soybean milk shop next door to Hu’s family died of illness, and Hu Xianzhong’s sister also had a fever. "At first, her parents thought that she was a cold fever (malaria), and the hospital also treated her as malaria. As a result, on the third day, she was swollen with perm, red skin and swollen lymph nodes, and she didn’t make it that night. Then the younger brother, father and mother … "

According to incomplete statistics, there are 135 local people who died of this epidemic, only with names. In order to prevent the spread of the epidemic, all the houses in Kaiming Street epidemic area were burned down.

On September 7th, Qiu Weizhong, the family member of the victims of Japanese germ warfare, pointed out the former site of Hu Xianzhong’s home in Kaiming Street (zebra crossing location) for the reporter. Xinhua News Agency reporter Feng Yuanshe

There is a two-story wooden building at No.5 Luohanjing in Quzhou City. Its former hostess, Huang Liao, was the first local plague patient killed after the Japanese army launched a germ war. Today, it is the Quzhou Exhibition Hall for the Bacteriological Warfare of the Japanese Invaders, and has been listed in the first batch of national-level memorial facilities and sites for the Anti-Japanese War. A stone pillar stands in the courtyard, engraved with the big black letter "1940".

"My uncle and aunt also died in the Japanese germ war in 1940." Curator Wu Jianping pointed to a wall with the names of the victims outside the exhibition hall and told reporters.

crime

"In 1940, 1942 and 1944, the Japanese army carried out large-scale germ warfare in Zhejiang. For example, when the Japanese army launched the Zhejiang-Jiangxi campaign in May 1942, it used to cast bacterial weapons. " Bao Xiaofeng, a second-level inspector and researcher at the committee of cpc zhejiang provincial committee Party History and Literature Research Office, said.

Bao Xiaofeng told reporters that in addition to these three large-scale attacks, from 1939 to 1945, the Japanese army carried out bacterial attacks in Zhejiang many times, releasing plague, cholera, paratyphoid fever, dysentery, diphtheria, anthrax and other germs. During the period of War of Resistance against Japanese Aggression, Zhejiang was one of the areas that suffered the most from germ warfare in China. The Japanese germ warfare directly caused about 60,000 deaths. The implementers are mainly the 731 troops and the "Rong" 1644 troops.

In Chongshan Village, Choujiang Street, Yiwu City, there was a terrible evil deed in Linshan Temple near the village. In November, 1942, Japanese germ warfare troops tricked plague patients into Linshan Temple for human experiments under the guise of treating diseases.

This is a monument erected at the gate of Linshan Temple, which was photographed on September 8th. Xinhua News Agency reporter Feng Yuanshe

Wang Jianzheng, a villager in Chongshan Village, told reporters that his great-grandmother and uncle both died in that disaster. "Wang Julian, the midwife who delivered my baby, was also caught in the temple and later escaped from the pit of the cesspit. She told my mother that my uncle died in the temple. "

On September 8, Wang Jianzheng, a villager from Chongshan Village, Choujiang Street, Yiwu City, pointed to the name of Wang Fang (Uncle Wang Jianzheng), a plague victim on the wall. Xinhua News Agency reporter Feng Yuanshe

According to a thorough investigation by Zhejiang Provincial Archives Bureau, there are 79 volumes and about 7,000 pages of files in the archives of Zhejiang Provincial Archives, including the details of the Japanese army’s use of aircraft and sending people to spread poisons on the spot, the investigation of the Japanese army’s germ warfare by the official institutions at that time, the monthly registration forms of epidemic diseases in various places and the countermeasures in various places, forming a complete and powerful evidence chain.

always remember

Ningbo, Yiwu and Quzhou have all built memorial facilities to expose the crimes of germ warfare committed by Japanese invaders and to remember the victims. In the exhibition hall of plague disaster in Kaiming Street, Qiu Weizhong, a family member of the victims who has collected historical materials for many years, brought a batch of copies of old newspapers: "From the historical materials collected so far, apart from Kaiming Street, Ningbo has been attacked by Japanese bacterial weapons in many places."

The exhibition hall (Yiwu) of the Historical Facts of Bacteriological Warfare of Japanese Invaders near Linshan Temple is open to the public this year. As the legal representative of the Association of Survivors of Bacteriological War Victims of Japanese Invaders in Yiwu, Wang Jianzheng often goes to the museum to have a look. He said that he hoped that more people would understand this historical fact.

In addition to serving as the curator of Quzhou Exhibition Hall for Bacteriological Warfare of Japanese Invaders, Wu Jianping also has a job, which is to provide voluntary service for the old people who suffered from "foot rot" during the Anti-Japanese War. At that time, many people suffered from a "rotten foot disease" wherever the Japanese army went.

In Xiakou Village, Xiachuan Town, Qujiang District, Quzhou City, Wu Fagui, an 83-year-old farmer, began to fester on his left calf and left foot from the age of four or five. "There is a Yao family ancestral temple in our village. At that time, China troops were stationed in the ancestral temple, and Japanese planes came to bomb it. Listening to the old people, everyone fled to the mountain and saw a bomb explode in the pond. " Wu Xiaorong, the son of Wu Fagui, pointed to a pond at the door and told the reporter, "My father was stabbed in the grass by the pond when he was a child, and then his feet began to rot."

In 2015, Wang Xuan, a part-time researcher at the Tokyo Judicial Research Center of Shanghai Jiaotong University, launched a public fundraising activity of "Rescue for Patients with Rotten Foot by Bacteriological Warfare" on the Internet through the China Foundation for Poverty Alleviation and the Shanghai Wang Zhengguo Trauma Medicine Development Foundation, and raised medical funds for patients with Rotten Foot for surgical treatment.

"Our surgical treatment was officially launched on September 18, 2015." Ye Chunjiang, deputy director of the Wound Repair Department of Quhua Hospital in Zhejiang Province, recalled that they had treated 87 patients in Quzhou and other places, and all of them were operated except for 7 who could not go to the operating table due to physical reasons. "I am very pleased to see that the wounds that have been repeatedly ulcerated on the legs of the old people are slowly healing."

Wu Fagui was the first old man to undergo surgery. Now, except for the occasional ulceration on his left foot, the "rotten foot disease" has basically recovered, and he often walks around the village with crutches. Wu Xiaorong said happily: "Dad has suffered for decades, and now he is finally comfortable."

(Xinhua News Agency, Hangzhou, September 18th)

　　Source: Yi Caixin

　　Author: Tong Muyao

　　On December 11th, 2020, science and technology innovation board IPO of Beijing Principal Century Technology Co., Ltd. (hereinafter referred to as Principal Century) successfully passed the meeting. In this IPO, Xin ‘an Century, together with Western Securities (002673, Share Bar) and Rongcheng Certified Public Accountants, plans to issue no more than 23,281,900 new shares and raise 688 million yuan for four projects, including upgrading information security products.

　　During Principal Century’s entry into science and technology innovation board, outstanding patent litigation, premium acquisition of assets, and sudden large dividends before listing became the focus of media attention.

　　In addition, Yicaixin also found that the credit sales of Principal Century increased, the subsidiaries suffered losses, the resume information of senior executives was in doubt, suppliers became "lazy" and fought with customer sales data.

　　Increased credit sales and losses of subsidiaries

　　Founded in August 2001, Principal Century is mainly engaged in the research and development, production, sales and related technical services of information security products supported by cryptographic technology, and is committed to solving information security problems such as identity security, communication security and data security in the network environment.

　　According to the prospectus, while the revenue and net profit of Principal Century increased from 2017 to 2019, the proportion of corporate accounts receivable balance in operating income also increased year by year.

　　From 2017 to January-June, 2020, the balance of accounts receivable of Xin ‘an Century was 85.3654 million yuan, 143.5321 million yuan, 188.2638 million yuan and 160.1941 million yuan respectively, accounting for 38.72%, 53.29%, 59.23% and 160.1941 million yuan of operating income respectively.

　　In 2018 and 2019, the company’s operating income increased by 22.18% and 18.01% respectively compared with the previous year. In the same period, the balance of accounts receivable increased by 68.14% and 31.16% compared with the previous year, and its growth rate was also higher than that of revenue. At the same time, its accounts receivable turnover rate continued to decrease during the reporting period.

　　In addition to serious credit sales in Principal Century, in the first half of 2020, the salary of Dong Jiangao and core technicians actually exceeded the total profit of the current period.

　　From 2017 to January-June, 2020, the total remuneration of directors, supervisors, senior managers and core technicians of the company was 4,175,900 yuan, 4,535,700 yuan, 4,863,200 yuan and 2,297,900 yuan, respectively, accounting for 8.80%, 5.81%, 5.38% and 1,019.98% of the company’s total profits in each period.

　　The total profit of Principal Century from January to June 2020 was 2,253,200 yuan, which was 80.91% lower than the total profit of 11,802,000 yuan from January to June 2019. For the reasons for the sharp decline in performance data including total profit, Principal Century explained that the main reason was the change in the consolidation scope of the company’s financial statements.

　　At the same time, more than half of the subsidiaries of Principal Century suffered net profit losses in the last year and the first phase.

　　According to the prospectus, as of the signing date of the prospectus on December 1, 2020, Principal Century has 6 subsidiaries, including 5 wholly-owned subsidiaries and 1 indirectly controlled subsidiary.

　　In 2019, Wuhan Xin ‘an Luojia Technology Co., Ltd. (hereinafter referred to as Xin ‘an Luojia), Chengdu Xin ‘an Century Technology Co., Ltd. (hereinafter referred to as Chengdu Xin ‘an), Shenzhen Xin ‘an Century Technology Co., Ltd. (hereinafter referred to as Shenzhen Xin ‘an), Shanghai Xinxuan Information Technology Co., Ltd. (hereinafter referred to as Shanghai Xinxuan), Beijing Anrui Junheng Technology Co., Ltd. (hereinafter referred to as Anrui Junheng) and Beijing Huayao Technology Co., Ltd. -2,059,900 yuan,-1,636,200 yuan,-657,500 yuan,-0,400 yuan and 4,043,900 yuan. Except for the profits of Principal Luojia and Huayao Technology, the net profit of the other four companies totaled 4,354,000 yuan, accounting for 4.75% of the net profit of the current consolidated caliber.

　　In the first half of 2020, all the above six subsidiaries suffered losses, with losses of 2,026,600 yuan, 1,272,200 yuan, 1,423,400 yuan, 1,067,800 yuan, 4,700 yuan and 1,172,200 yuan respectively. The total net profit loss was 6,966,900 yuan, which was nearly twice the net profit of 3,589,300 yuan consolidated in the current period.

　　Suppliers become "lazy" and fight with customer data.

　　In addition to the losses of subsidiaries, the upstream and downstream suppliers and customers of Principal Century are also worthy of attention.

　　Looking at its upstream, suppliers are listed as untrustworthy executors, restricting consumption, and have been listed in the business exception list because of the falsification of public information.

　　Beijing Huayi Zhiyan Technology Co., Ltd. (hereinafter referred to as Huayi Zhiyan) was the second largest supplier of Principal Century in 2018 and 2019. Principal Century purchased servers and other products from it, and the amount incurred was 7,765,500 yuan and 12,785,400 yuan, accounting for 10.42% and 13.78% of the total purchase amount in the current period.

　　Huayi Zhiyan was established in August 2016. At present, the shareholders are Zhang Lihua, Mazidong and Yin Ruishan, with the shareholding ratio of 50%, 25% and 25%.

　　It is worth noting that Huayi Zhiyan was listed as an executor of dishonesty by Laishui County People’s Court in July 2020. According to document No.455 (2020) J.0623, Zhang Lihua, the major shareholder of Huayi Zhiyan, failed to fulfill Liu’s loan of 3.45 million yuan and its interest, and Huayi Zhiyan was listed as an executor of bad faith because of its joint liability for repayment.

　　(Screenshot from China Executive Information Open Network)

　　According to public information, in addition to being dragged down by shareholders and becoming an executor of dishonesty, Huayi Zhiyan also has eight messages restricting consumption in 2020.

　　Another supplier, Shandong Fisherman Information Technology Co., Ltd., was the fifth largest supplier of Principal Century in 2018, and the amount of products such as encryption cards purchased by Principal Century in that year was 2,732,200 yuan. In 2016, the company was listed in the list of business anomalies by Weihai Municipal Market Supervision Administration for concealing the real situation and practicing fraud, and was removed from the list five days later.

　　In addition to the supplier problem, there is a "fight" between Principal Century’s sales to customers and the data disclosed by the other party.

　　According to the prospectus, in 2019, Shandong Kyushu Xintai Information Technology Co., Ltd. (hereinafter referred to as Kyushu Xintai) was the fourth largest customer of Principal Century, and the sales amount to it in that year was 7,064,400 yuan, accounting for 2.23% of the main business income.

　　Kyushu Xintai was listed on the New Third Board on August 1, 2016. According to the 2019 financial report disclosed by the company in the New Third Board, in that year, Principal Century was the largest supplier of Kyushu Xintai, with a purchase amount of 5,662,800 yuan, and the data there was 1,401,600 yuan less than the corresponding data disclosed in the prospectus.

　　The resume of senior executives is doubtful.

　　In addition to the above problems, there are doubts about the resumes of directors, supervisors and other senior executives in Principal Century Prospectus.

　　As of the signing date of the prospectus, the board of directors of Xin ‘an Century consists of seven directors, namely, Li Wei, Wang Yixin, Ding Chun, Yuli, Jin Haiteng, Yuan Liansheng and Zhang Shiwei, among whom Jin Haiteng, Yuan Liansheng and Zhang Shiwei are independent directors. The board of supervisors of the company consists of three supervisors, namely, Wang Zongbin, Bei Shaofeng and Zhang Yangbao, among whom Wang Zongbin is the chairman of the board of supervisors.

　　Yu Li, the director and general manager of Xin ‘an Century Shareholder Caitong Innovation Investment Co., Ltd. (hereinafter referred to as Caitong Innovation), became a director in 2019. Before that, Yu Li worked as a technician in CRRC Qishuyan Locomotive Co., Ltd. (hereinafter referred to as CRRC Qishuyan) from August 1996 to August 2000, and served as Zhonghe Venture Capital Management Co., Ltd. from September 2006 to October 2017.

　　What is puzzling is that Qixin. com shows that CRRC Qishuyan was established on June 26th, 2007, and its legal representative is Yao Guosheng. It used to be named Changzhou Qishuyan South Locomotive and Rolling Stock Co., Ltd. and CSR Qishuyan Locomotive Co., Ltd., and there is no same name or previous name as CRRC Qishuyan. The company was established about 11 years later than the directors’ entry time disclosed in the prospectus, and the reason is unknown.

　　At the same time, Qixin. com showed that Zhonghe Venture was established in October 2006, which was about one month later than the entry time of director Yu Li.

　　In addition to the director’s entry time 11 years earlier than the establishment time of the enterprise, there is also a supervisor’s work resume in doubt.

　　Bei Shaofeng joined Principal Century as a supervisor in May 2020. Before that, he worked as a UNIX software development engineer in Beijing Beida Jade Bird Commercial Information System Co., Ltd. (hereinafter referred to as Jade Bird System) from May 1999 to April 2001.

　　What is puzzling is that Qixin. com shows that Beijing Beida Jade Bird Commercial Information System Co., Ltd. was revoked in January 2002. At the same time, according to public information, a company that used to be known as Jade Bird System and is now known as Boya Software Co., Ltd. (hereinafter referred to as Boya Software) was established in September 2002. Before June 18, 2009, Jade Bird System changed its name to Beijing Beida Jade Bird International Software Technology Co., Ltd., and then changed its name to Boya Software in December 2010. At present, it is not known which side of the envelope has problems, but if we look at the establishment time of Boya Software, the supervisor Bei Shaofeng’s entry time is much earlier than the establishment time of the enterprise.

　　To sum up, although Principal Century successfully held the meeting this time, there are still some doubts in its prospectus that need to be explained.

This article was first published on WeChat WeChat official account: Yicaixin. The content of the article belongs to the author’s personal opinion and does not represent Hexun.com’s position. Investors should operate accordingly, at their own risk.

On the first day of the new year, Jin Dong Song Jia’s new drama "Even if there is a flurry" was first launched, with Beijing Satellite TV, Jiangsu Satellite TV, Tencent Video and Iqiyi broadcasting, which can be regarded as the channel configuration of the last star drama!

The premiere ratings are the first, and it seems that there is nothing to play in the recent star drama!

Cat’s eye heat is the fourth, and the heat is not bad. Are they all scolded?

Douban’s comments received a flood of bad reviews, mainly saying that Jin Dong’s performance as a tyrant and veteran cadre for ten years was still full of dad’s flavor, which was very unpleasant!

Song Jia’s crazy batch of beautiful women, the behavior logic is also very unreasonable!

Do you have to engage in gender opposition in entrepreneurial workplace dramas?

After watching 6 episodes, I think it’s ok, I can watch it!

Feel free to analyze the slots of the first two episodes!

1. The dress of public relations company is really a little old-fashioned!

The employees of the male owner Tang Chen’s public relations company are either white shirts or suits, like real estate agents, which really don’t conform to people’s cognition of public relations companies!

2.46-year-old Jin Dong is obviously old. It’s not like playing a boss in his thirties!

The skin condition is very bad, and my face is getting fat!

3. The heroine played by Song Jia taught others at the wedding dress shop at the beginning, which is a bit too much!

As soon as the hostess appeared in the bridal shop, she saw a woman trying on a wedding dress, the man playing games, and the woman didn’t answer his opinion!

The hostess couldn’t help lecturing the man: She didn’t make up her mind before asking you. Did you have a good look at her?

Then tell the woman: the wedding is your own, what you wear is up to you, and you don’t have to ask him everything!

The hostess is really too nosy, even if she doesn’t like it, can’t she be so direct?

How about another way?

4. Why do public relations companies use so much paper?

Subordinate sends a planning case to the boss, don’t you use PPT?

Why print it out? Don’t you waste paper?

5. Does the man trust the woman too much? Trade secrets and passwords?

The male host and the female host belong to different public relations companies, and they are competitors. The male host also easily reveals the customer’s situation and his own account passwords, which provides opportunities for the female host to grab customers and expose information!

Since it is set by elite people, can’t it be elite in the end?

Expose your weaknesses casually?

The hostess not only taught strangers a lesson, but also taught her fiance a lesson. She didn’t look at the last straw that people were about to close down, and said not to cooperate with Xi Xing!

Two career strongmen, both like to preach, but the man is a head lower in front of the woman!

Double strong doesn’t seem to be suitable?

Especially peers!

6. The man has gone to Xi Xing to preside over crisis public relations. Why does the woman have to write a plan and prepare to cut off Hu?

Two people happen to coincide to make the same plan!

The man is the boss, and the company is about to close down, just waiting for this single help!

The woman is an employee of another company. Is it really necessary to kill the man in order to climb up?

Even if he went to the wedding dress shop and stood him up, he wouldn’t die, would he?

7. Does the public relations company ask the capable subordinates to be promoted or resigned?

Because the public relations plan issued by the female host is the same as the operation of the male host company, the company suspects that the female host disclosed it to the male host, so it requires her to either resign and get married or break up and get promoted!

Is this reasonable?

If the two people’s plans are consistent, must the woman reveal the plan to the man?

Can’t the woman copy the man’s?

Can’t it be that two heroes think alike?

The hostess can’t talk very well at ordinary times, so why didn’t she explain it again?

The two haven’t seen each other for several days, and each of them has done his own thing. It can only be said that it happened by chance!

It is unreasonable for the company to do so!

The reaction of the hostess is also unreasonable. Why is she led by the boss?

Why can’t you explain, why can’t you resist, why can’t you quit, find another job, or help the man tide over the difficulties?

8. The man is really macho, but the woman is too arrogant!

The woman asked the man, do you want to break up and get promoted or resign and get married?

The man said firmly: resign and get married, I will support you!

He said that this is the most sensible thing to do, and it is indeed a sensible thing to do. After all, the man is the boss of the company, raising so many people, and if he makes money, he can earn more money, while the woman only works for others, and her resignation only involves herself!

However, his expression method makes the hostess feel very disrespected. After three years of love, she didn’t even know that the hostess was a strong woman?

How is it possible for you to keep it?

The hostess originally wanted to listen to her attitude, but the one who was in a hurry could only say that she broke up!

And she chose to break up and get promoted, which she felt could realize her self-worth!

But have you two publicists ever thought about the third option, that is, the hostess resigns and finds another company?

Since the business level is so good, can’t you find another job?

There is a fourth option. After the woman resigns, she joins the male company. The male company is facing a bankruptcy crisis. Can’t the two of them work together to tide over the difficulties?

Do you have to engage in internal friction?

Many people hate the man because of this paragraph, but I don’t think so!

First of all, it is indeed the most sensible thing to let the woman resign. Secondly, isn’t most men male chauvinism in reality?

Do you have to beautify men in film and television dramas?

"Courtyard of the County Party Committee" beautifies the leadership, and everyone doesn’t like it. Is it true that "Even if there is a flurry" beautifies men, everyone likes it?

This paragraph is deliberately creating conflicts, and this is also the basis for the subsequent development of this drama!

If the foundation is gone, the follow-up story may not exist!

Building a house on an unreasonable basis can the house be solid?

Two strong men are set up, their preferences are similar, they are easy to approach and conflict, so some people think that complementarity is the most stable!

For example, if the man is a male chauvinist, he must not find a strong woman. Wouldn’t it be harmonious to find a small woman?

If a woman is a strong woman, she can’t find a male chauvinist and a man who can respect women, right?

So male chauvinism is not discovered now, is it?

You haven’t found out after three years of love?

You didn’t find out until you talked about marriage?

This is not reasonable!

True male chauvinism will be reflected in all aspects and details. It is impossible for the two to get married three years ago!

9. When a woman breaks up, she breaks up. Why should she ruin the man?

The original crisis has been solved, and Mr. Ye personally delivered the purchase contract, so the male company won’t have to go bankrupt when it is acquired!

And the video was sent out with the male main account!

This is obviously what the hostess did, right?

Or a hacker?

Hacked the male master account and exposed the video?

Mr. Ye asked the male owner to solve it within 24 hours, and there is still talk about the acquisition!

The woman insisted on asking him to try on the wedding dress at this time, but the man couldn’t get rid of it and had to go. The woman kept asking: Will you marry me?

The man always wanted to know why the woman wanted to hurt him.

The hostess only said: if there is one person to sacrifice, it can only be you!

The woman recalled the scene of her father’s death. Is it related to the man’s death?

Otherwise, it would be too unreasonable!

Of course, some people’s brains can’t be calculated according to normal people, such as mental derangement, abnormal condition and so on!

The heroine of this play is a crazy beauty, so it seems normal to do anything out of line!

The above are the slots of the first two episodes. I still feel that I can watch it without taking stock. After taking stock, I feel that it is good to look at it as a joke, but it is not funny at all, but it is quite abusive!

You see so many slots, will you still see them?

# Jin Dong #

Recently, Jiangxi Provincial Medical Security Bureau issued "Several Measures for Convenience and Benefits of Medical Security Departments in the Province" and launched 20 measures for convenience and benefits. It is mentioned that there is no waiting period for the treatment of the needy population, which can be "enjoyed immediately"; Outpatient chronic and special diseases are directly settled for medical treatment across provinces and different places; The masses can implement instant settlement by swiping their cards in designated village (community) clinics; Before the end of this year, the masses went to different places for medical treatment, and canceled the referral and other proof materials.

Cancel the capping line for reimbursement of serious illness insurance such as urban and rural subsistence allowances.

Ordinary residents participate in medical insurance for urban and rural residents by combining individual contributions with government subsidies, and can pay through various channels such as WeChat, tax App, banks and offline halls. The individual contributions of the poor population to participate in the medical insurance for urban and rural residents are partly funded by the government according to regulations. For the newly identified population in difficulty after the payment period of centralized medical insurance for urban and rural residents, they can be insured at any time and enjoy treatment at any time, without waiting period for treatment.

If the employee’s medical insurance insured person is interrupted for 3 months (inclusive) due to the transfer of medical insurance relationship, he can go through the formalities of medical insurance premium payment in the transferred medical insurance agency, and enjoy the waiting period without treatment after payment, and enjoy the treatment from the next day of payment. The treatment during the interruption period can be enjoyed retroactively according to regulations. Institutions and institutions that recruit, select and serve in different places can go through the transfer procedures of medical insurance before the establishment of personnel or the salary relationship, so as to ensure the seamless connection of the treatment of the employees.

We will fully implement the policy of coordinating outpatient services for urban and rural residents, and there is no deductible line for medical treatment in designated medical institutions at or below the first level, and the reimbursement rate will reach about 65%. Insured residents can implement instant settlement by swiping their cards in designated village (community) clinics. From January 1, 2023, the outpatient medical insurance for employees will be co-ordinated, and the proportion of reimbursement for medical treatment in designated medical institutions will be no less than 50%, so as to gradually realize the mutual assistance of individual medical insurance accounts for employees. The implementation of outpatient treatment of chronic and special diseases, drugs, diagnosis and treatment items and medical consumables that meet the needs of outpatient treatment of chronic and special diseases can be included in the scope of fund payment according to regulations.

Within the scope of the basic medical insurance policy for employees and urban and rural residents, the proportion of hospitalization expenses paid by the fund is stable at around 80% and 70% respectively. The deductible line of serious illness insurance for destitute dependents, orphans, urban and rural subsistence allowances and people returning to poverty will be reduced by half, accounting for 25% of the annual per capita disposable income of urban and rural residents, and the reimbursement ratio of serious illness insurance will be increased by 5 percentage points to 65%, and the top line will be cancelled.

The relief object is identified at any time, insured at any time, and enjoys treatment at any time. Before the end of 2022, the recipients who have standardized referral and sought medical treatment in the province will be given inclined assistance according to the application after being paid by the triple system of basic medical insurance, serious illness insurance and medical assistance, so as to effectively prevent poverty caused by returning to poverty due to illness.

Further simplify the handling links and evaluation procedures of designated medical insurance applications, shorten the waiting time of medical institutions, and the evaluation time shall not exceed 3 months from the date of accepting the application materials.

Realizing "Commitment System" for Self-service Filing for Medical Treatment in Different Places

Simplify the filing procedures for medical treatment in different places. On the basis of canceling the residence permit, the certificate of the neighborhood Committee of the resettlement place, the work certificate of the unit, the household registration book and other certificates for medical treatment in different places, the referral and emergency proof materials will be further cancelled before the end of 2022, and the "commitment system" self-service filing will be fully realized.

By the end of 2022, we will realize the cross-provincial direct settlement and full coverage of the treatment expenses for chronic and special diseases in five major outpatient clinics, including hypertension, diabetes, radiotherapy and chemotherapy for malignant tumors, uremia dialysis and anti-rejection treatment after organ transplantation in 12 overall planning areas of the province.

Relax the selection scope of designated medical institutions for outpatient chronic and special diseases. According to the actual situation, the medical insurance department in the overall planning area can allow the insured persons with chronic and special diseases in outpatient clinics to choose two or more designated medical institutions as designated hospitals for chronic and special diseases in outpatient clinics before October 1, 2022.

For the insured persons with chronic diseases who really need it, after being evaluated by doctors in designated medical institutions, the prescription dosage will be relaxed to 12 weeks, and the medical insurance fund will be settled according to regulations.

The medical insurance handling service hall provides delayed service on weekends.

For drugs and medical consumables purchased with centralized quantity, the medical insurance fund shall be directly settled with pharmaceutical enterprises, so as to speed up the withdrawal of funds from enterprises and reduce the transaction costs of enterprises.

Revise the list of public service items and service guide of the platform, standardize the online processing process, and realize the "all-process network operation" and "one-network operation" of the whole process business such as new product hanging, information change and distribution relationship confirmation of pharmaceutical enterprises.

Optimize the service process of medical insurance management. Improve the standardization level of medical insurance handling services. In accordance with the principles of "reducing materials, processes and time limits" and "minimum necessity", the List of Administrative Services for Medical Insurance in Jiangxi Province was revised to further optimize the service process, simplify the application materials and shorten the processing time limit.

The service halls of medical insurance agencies at all levels provide delayed services at noon on weekdays, weekends and legal holidays, smooth the channels of appointment services, and provide 365-day "non-closing" medical insurance window handling services.

Promote the "online office" of high-frequency medical insurance services. Through the online service hall of Jiangxi Medical Insurance, the "Jiangxi Smart Medical Insurance" App, and the "Ganfutong" medical insurance zone, the high-frequency service items in the medical insurance field, such as enrollment registration, enrollment information change, basic medical insurance relationship transfer and connection, and personal account details inquiry, have been realized, and the scope of "inter-provincial communication" and "intra-provincial communication" has been continuously expanded.

Promote the use of the whole process of medical insurance electronic certificate in designated medical institutions

Accelerate the construction of the five-level medical security management service system at the provincial, city, county (district), township (street) and village (community). By the end of 2022, the medical security service items such as urban and rural residents’ insurance registration and medical treatment in different places will be included in the service scope of grassroots government service outlets, so that the insured can "do it nearby, do it once and do it quickly".

For the medical expenses that are not directly settled by the insured, the medical insurance department in the overall planning area shall relax the reporting time limit for manual (sporadic) reimbursement of medical expenses according to the actual situation, and shall not refuse to accept the sporadic reimbursement application of the insured people on the grounds of exceeding the reporting time limit.

The conditions for employees to enjoy maternity medical expenses and maternity allowance shall be implemented in accordance with the Notice of the General Office of the People’s Government of Jiangxi Province on Printing and Distributing the Implementation Measures for the Merger of Maternity Insurance and Basic Medical Insurance for Employees (No.94 [2019] of Gan Fu Ting Zi), and other existing additional conditions shall be cancelled before October 1, 2022. The conditions for urban and rural residents to enjoy reimbursement of maternity medical expenses are consistent with basic medical insurance.

Realize the multi-scenario application of medical insurance in electronic certificate, public service inquiry, personal insurance information inquiry and so on, and promote the whole process of medical insurance services such as registration, medical treatment, payment, and drug collection in designated medical institutions, so that the insured personnel can have one yard in hand and have no worries about medical insurance.

Carry out activities such as "leaders receiving visits to Japan", "hospital reception day" and "enterprise reception day" to interpret the medical insurance policy and respond to the concerns of the masses.

Weilai Automobile provides users with a convenient charging solution, and the service fee for battery replacement by code scanning is 180 yuan every time, which is consistent with the one-click start-up service.

Weilai has always been committed to improving the experience of car owners. As a car owner, you can enjoy the privilege of replacing Weilai battery for free for life on the basis of enjoying the lifetime free warranty service of your car. This policy covers all non-first-time car owners, and the battery replacement cost of operating vehicles consists of battery replacement cost plus electricity and service charges.

Specifically, the electricity price and service charge at the place where the power exchange station is located may be slightly higher than those at the surrounding operation sites. On July 7, 2020, Weilai launched a new power exchange mode for non-first-time car owners and operating vehicles, in which the power exchange cost includes battery cost (135 yuan) and service fee, and this policy will take effect on July 10. For users who buy new ES8, ES6 and EC6, they can enjoy the right of free power exchange for life.

Weilai provides car owners with flexible battery selection. Users can choose battery packs with different capacities according to their needs, and users of standard battery packs can get compensation, such as 200 credit days, when changing power across levels. The excellent performance and battery technology of Weilai ES6 ensure that users can enjoy long battery life without worrying about battery performance attenuation. According to the actual data of the owner, even if driving more than 150 thousand kilometers, the endurance attenuation is only about 5%.

Although the power exchange mode has alleviated users’ endurance anxiety to a certain extent, there are still challenges. For example, in second-and third-tier cities, due to insufficient distribution of power exchange stations, it may be necessary to wait on holidays, and some sites may be remote. In order to improve this situation, Weilai is constantly promoting the construction of power exchange stations, and is committed to covering major areas to meet the needs of more car owners.

To sum up, the cost of Weilai power station mainly depends on the service cost, and Weilai’s life-long free power exchange service makes car owners feel at ease during use. With the improvement of facilities, Weilai will continue to improve the user experience and solve potential problems.

　　According to the WeChat official account message of "City Talk" WeChat, processed grain products, edible agricultural products, sugar, tea and related products, dairy products, beverages, alcohol, cakes, roasted seeds and nuts and nut products … … Are these foods that we often eat safe? Recently, the General Administration of Market Supervision organized food safety supervision and sampling inspection.

　　This sampling inspection includes processed grain products, edible agricultural products, sugar, tea and related products, dairy products, beverages, alcohol, cakes, roasted seeds and nuts, biscuits, starch and starch products, convenience foods, potatoes and puffed foods, egg products, bean products, bee products, vegetable products, fruit products, meat products, aquatic products, condiments, frozen drinks, quick-frozen foods, candy products and so on.

　　one

　　650 batches of 27 categories of food samples:

　　● 13 batches of 7 categories of food, including processed food, dairy products, cakes, convenience foods, potatoes and puffed foods, fruit products and infant formula foods, were unqualified.

　　● The main problems found are microbial pollution, excessive use of food additives, substandard quality indicators, and inconsistency between quality indicators and labeling values.

　　2

　　Unqualified food found in sampling inspection:

　　● The General Administration of Market Supervision has instructed provincial-level market supervision departments such as Jilin, Shanghai, Jiangsu, Zhejiang, Anhui, Shandong, Hubei, Hunan, Guangdong, Guangxi and Shaanxi to immediately organize verification and disposal, find out the product flow, and urge enterprises to take measures such as recalling unqualified products from the shelves to control risks; Strictly deal with violations of laws and regulations according to law; Timely disclose the risk prevention and control measures and verification and disposal of enterprises to the public, and report to the General Administration.

　　Specific situation

　　I. Microbial pollution

　　(1) The fruit yogurt oats sold by Taobao Baiwei Snacks Enterprise Store (operated by Zoucheng Baiwei E-Commerce Co., Ltd., Jining City, Shandong Province) and commissioned by Shandong Xinwo E-Commerce Co., Ltd. to produce by Shandong Guangtou Li Ji Food Co., Ltd., in which the number of molds does not meet the national food safety standards.

　　(II) Nut kudzu root powder sold by Tmall Gewa flagship store (operator is Hubei Gewa Food Co., Ltd.) in Tmall Mall (online shop) and nominally produced by Yuanxingtang (Anhui) Health Industry Co., Ltd. entrusted by Suhe Agricultural Products Sales Cooperative Association of Binhai County, Yancheng City, Jiangsu Province, in which the total number of colonies and the number of molds do not meet the requirements of product implementation standards.

　　(3) Osmanthus Jelly sold by Manwu Department Store in Xiufeng District, Guilin City, Guangxi Zhuang Autonomous Region and nominally produced by Guilin Valley Mill Food Co., Ltd., in which the number of Staphylococcus aureus and the total number of colonies do not meet the national food safety standards.

　　(4) Handmade glutinous rice blocks sold by Tmall Lvhui food franchise store (operator is Yuyao Lvhui International Trade Co., Ltd., Ningbo City, Zhejiang Province) in Tmall Mall (online store) and nominally produced by Hemudu Yuansheng Rice Cake Factory, Yuyao City, Ningbo City, Zhejiang Province, in which the total number of colonies does not meet the national food safety standards.

　　(5) The Shuimo Rice Cake, which is sold by Taobao’s three-person snack shop (operated by lanshan district Qunbo Food Store in Linyi City, Shandong Province) and nominally produced by Haishu Zenghui Food Factory in Ningbo City, Zhejiang Province, in which the total number of colonies does not meet the national food safety standards.

　　(VI) Haokoufu bean crispy rice (fried puffed food) sold by Jiameijia Chencang Garden Store of Shaanxi Baoji Shopping Mall Co., Ltd. and nominally manufactured by Shaanxi Baoji Haokoufu Food Co., Ltd., in which the total number of colonies does not meet the national food safety standards.

　　Second, the problem of out-of-range and over-limited use of food additives

　　(1) Chuncui infant formula (0— 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 0 & mdash; 6 months old, country of origin: Australia), in which the detection value of vanillin does not meet the national food safety standards. Changsha Aoyou Dairy (China) Co., Ltd. objected to the inspection results and applied for re-inspection; After re-inspection, the conclusion of initial inspection shall be maintained. The Market Supervision Bureau of Wangcheng District of Changsha City has urged Aoyou Dairy (China) Co., Ltd. to immediately recall and seal 6,726 cans of unqualified food, confiscate the illegal income of 20,300 yuan and impose a fine of 9,621,300 yuan. Ningbo Yinzhou District Market Supervision Bureau confiscated illegal income and imposed a total fine of 11,500 yuan on the mother-baby products store of Mommy Garden in Jison, Yinzhou, Ningbo, which sold unqualified products.

　　(2) Tianshan Mume, which is sold by Pinduoduo Dixiangwei Food Franchise Store (operated by Guangdong Guangzhou Dixiangwei Food Co., Ltd.) in Pinduoduo (mobile APP) and nominally produced by Kaishili Food Factory in Jiexi County, Jieyang City, Guangdong Province, and the detected values such as the sum of the respective dosages of brilliant blue, amaranth and colorants of the same color in the mixed use of them in the maximum dosage ratio do not meet the national food safety standards.

　　(3) The ebony sold by Pinduoduo Lexiangxiong official flagship store (operated by Shandong Weifang Qiqi E-Commerce Co., Ltd.) in Pinduoduo (mobile phone APP) and nominally commissioned by Shandong Weifang Qiqi E-Commerce Co., Ltd. to produce by Liaoning Huludao Xingcheng Hongfa Food Co., Ltd., among which the detected values such as the sum of the respective dosages of brilliant blue, carmine and colorants of the same color in the mixed use ratio of their maximum dosages do not meet the national food safety standards.

　　(4) Tianshan Mume, which is sold in Pinduoduo (mobile APP) by Pinduoduo’s official flagship store of five seasons food (operated by Guangdong Jieyang Duobaoyu E-commerce Co., Ltd.) and commissioned by Guangdong Jieyang Jiexi Fifth Season Food Co., Ltd. to produce by Shuangmao Food Factory in Jiexi County, Guangdong Province, in which the detection values of bright blue and amaranth do not meet the national food safety standards.

　　(5) Buckwheat cold noodles sold by Tmall Juzhen Huipin Flagship Store (operated by Jilin Juzhen Food Development Co., Ltd.) in Tmall Mall (online store) and produced by Jilin Juzhen Huipin Trading Co., Ltd. and meihekou city Meihechun Food Co., Ltd. in Tonghua City, Jilin Province, in which the detection values of sorbic acid and its potassium salt (calculated by sorbic acid), dehydroacetic acid and its sodium salt (calculated by dehydroacetic acid) do not meet the national food safety standards.

　　Third, the quality index is not up to standard

　　The spicy stone cakes (cakes) sold by Taobao Qin Restaurant (the operator is pucheng county Qin Restaurant Specialty Store in Weinan City, Shaanxi Province) and nominally produced by Shaanxi Maonv Food Co., Ltd., in which the peroxide value (measured by fat) does not meet the national food safety standards.

　　Fourth, the quality index does not match the label value.

　　The high calcium buffalo milk sold by Guangxi Guanye Investment Development Co., Ltd. Nanning Anji Wanda Store and produced by Guangxi Shibu Dairy Co., Ltd. entrusted by Guangxi Yangli Food Co., Ltd. met the national food safety standards, but did not meet the product labeling requirements. Guangxi Shibu Dairy Co., Ltd. objected to the inspection results and applied for re-inspection; After re-inspection, the conclusion of initial inspection shall be maintained.

　　Annex 1

　　Small knowledge of some unqualified inspection items

　　First, mold

　　Mold is an indicative index to evaluate the quality of food hygiene. The number of molds in food refers to the number of mold colonies formed in 1g or 1mL of food samples after being treated and cultured under certain conditions. If the mold in food exceeds the standard seriously, it will destroy the nutritional components of food, make food lose its edible value, and may also produce mycotoxin; Long-term consumption of food with excessive mold may endanger human health. National Food Safety Standard for Blending Cereal Products (GB 19640— In 2016), it is stipulated that the mold test results of five samples of the same batch of brewed cereal products should not exceed 102CFU/g, and the test results of two samples are allowed to exceed 50CFU/g at most. Convenient Blended Products (Q/AYXT 0004S— 2021) stipulates that the test results of mold in five samples of the same batch of products for convenient preparation shall not exceed 102CFU/g, and the test results of two samples are allowed to exceed 50CFU/g at most. The reason why the number of molds in brewed cereal products and instant brewed products exceeds the standard may be that the raw materials or packaging materials are contaminated by molds, or that the sanitary conditions of the products are not well controlled during production and processing, or that the storage and transportation conditions of the products are improper.

　　Second, the total number of colonies

　　The total number of colonies is an indicative microbial index, not a pathogen index, which reflects the hygienic status of food in the production process. If the total number of colonies in food seriously exceeds the standard, it will destroy the nutritional components of food and make food lose its edible value; It will also accelerate the deterioration of food, which may endanger human health. Convenient Blended Products (Q/AYXT 0004S— 2021) stipulates that the detection results of the total number of colonies of five samples of the same batch of products for convenient preparation shall not exceed 105CFU/g, and the detection results of two samples are allowed to exceed 104CFU/g at most. National Food Safety Standards for Pastry and Bread (GB 7099— 2015) stipulates that the total number of colonies of five samples of the same batch of pastry food products should not exceed 105CFU/g, and the detection results of two samples are allowed to exceed 104 cfu/g at most; "rice cake" (SB/T 10507— In 2008), it was stipulated that the microbial index of Shuimo rice cake should meet the national food safety standard "Quick-frozen noodle rice products" (GB 19295— "Cooked food" in 2011), that is, the test results of the total number of colonies of five samples of the same batch of products shall not exceed 105CFU/g, and the test results of one sample are allowed to exceed 104 cfu/g at most; National Food Safety Standard Puffed Food (GB 17401— 2014）It is stipulated that the total number of colonies of five samples of puffed food in the same batch should not exceed 105CFU/g, and the detection results of two samples are allowed to exceed 104CFU/g at most. The reason why the total number of colonies in instant concocted products, cakes, rice cakes and puffed food exceeds the standard may be that the enterprise has not strictly controlled the sanitary conditions in the production and processing process as required, or it may be related to the lax packaging and sealing of the products or improper storage and transportation conditions.

　　Third, Staphylococcus aureus

　　Staphylococcus aureus is a common pathogen. Once food is not properly preserved, Staphylococcus aureus can multiply in large numbers. Eating food seriously contaminated by Staphylococcus aureus may cause food poisoning, resulting in severe vomiting, fever, diarrhea and other symptoms. Limit of pathogenic bacteria in food according to the national standard of food safety (GB 29921— In 2013), the detection results of Staphylococcus aureus in five samples of the same batch of pastry food products should not exceed 103CFU/g, and the detection results of one sample should exceed 102CFU/g at most. The reason why the number of Staphylococcus aureus in cakes exceeds the standard may be that the production and processing personnel carry bacteria and cause pollution; It may also be raw material pollution, improper control of sanitary conditions in the production process, incomplete sterilization and cross-contamination of products; It may also be related to improper storage and transportation of products.

　　Iv. Vanillin

　　Vanillin is a commonly used food additive. Because of its vanilla bean aroma and rich milk aroma, it is widely used in all kinds of flavored foods that need to increase milk aroma, especially dairy products, baked goods, beverages and edible oil. Using vanillin according to the standard requirements will not do harm to human health, but a large intake of vanillin will lead to dizziness, nausea and other symptoms, and in severe cases, it will cause liver and kidney damage. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), it is stipulated that no edible spices should be added to infant formula food from 0 to 6 months, and vanillin can be used in limited amounts for older infants and young children’s formula food according to regulations. The reason for the detection of vanillin in the first stage of infant formula milk powder may be that the company did not completely clear the scene when switching the food production lines for infants of different months; It may also be that illegal traders illegally add such substances in order to achieve the purpose of shoddy and fake.

　　Five, bright blue

　　Brilliant Blue, also known as Edible Blue No.2, is a water-soluble non-azo compound, which is a common synthetic colorant and widely used in food production. If the food with excessive bright blue is ingested for a long time, it may be teratogenic and carcinogenic. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), the maximum dosage of brilliant blue in preserved fruits was 0.025g/kg. The detection value of bright blue in preserved fruits exceeds the standard value, which may be caused by inaccurate measurement in the production process, excessive use by production enterprises to improve the color and market value of products, or adulteration and fraud by enterprises.

　　Six, amaranth red

　　Amaranth red, also known as blue acid red and azo compounds, is a common synthetic colorant and widely used in food production. If the food with amaranth exceeding the standard is ingested for a long time, it may be teratogenic and carcinogenic. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), the maximum dosage of amaranth in preserved fruits was 0.05g/kg. The reason why the detection value of amaranth in candied preserved fruits exceeds the standard value may be that the production enterprises overuse it to improve the color and market value of the products, or that the enterprises adulterate and falsify the pigments.

　　Seven, the same color colorants when mixed use of their respective dosage of the proportion of the sum of the maximum amount.

　　Colorants, also known as food pigments, are used to give and improve the color of food. If it is taken excessively for a long time, it will increase the burden on the liver and gastrointestinal tract and cause certain harm to human health. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), it is stipulated that the sum of the ratio of the respective dosage to the maximum dosage of colorants with the same color should not exceed 1. The reason why the sum of the ratio of the respective amounts of colorants with the same color in candied fruit to the maximum amount exceeds the standard value may be that the production enterprises do not understand the national food safety standards and add more colorants with the same color in excess, or that the amount of colorants with the same color is not strictly controlled in the production and processing process.

　　Eight, carmine

　　Carmine, also known as scarlet, brilliant scarlet and azo compounds, is a common synthetic colorant and widely used in food production. There is no poisoning phenomenon of carmine in animal experiments, but if the food with carmine exceeding the standard is ingested for a long time, it may be teratogenic and carcinogenic. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), the maximum dosage of carmine in preserved fruits was 0.05g/kg. The reason why the detection value of carmine in preserved fruit exceeds the standard value may be that the final product carmine exceeds the standard due to inaccurate measurement in the production process, or that the production enterprise overuses it to improve the color and market value of the product, or that the enterprise adulterates and falsifies and abuses the pigment.

　　Nine, sorbic acid and its potassium salt (in sorbic acid)

　　Sorbic acid and its potassium salt have strong antibacterial activity and good antiseptic effect, and are widely used as food preservatives at present. Long-term consumption of foods with excessive sorbic acid and its potassium salt may cause harm to the growth of liver, kidney and bone. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— 2014) stipulates that sorbic acid and its potassium salt (calculated by sorbic acid) shall not be used in other grain flour products. The reason why sorbic acid and its potassium salt (calculated by sorbic acid) were detected in buckwheat cold noodles may be that enterprises used it beyond the scope in order to extend the shelf life of the products or make up for the poor sanitary conditions in the production process.

　　X. dehydroacetic acid and its sodium salt (in dehydroacetic acid)

　　Dehydroacetic acid and its sodium salt, as a broad-spectrum food preservative, have strong inhibition ability to mold and yeast. Dehydroacetic acid and its sodium salt can be completely absorbed by human body, and can inhibit various oxidases in human body. Excessive intake of dehydroacetic acid and its sodium salt for a long time will be harmful to human health. National Standard for Food Safety-Standard for the Use of Food Additives (GB 2760— In 2014), dehydroacetic acid and its sodium salt are not allowed to be used in other grain flour products. The reason why dehydroacetic acid and its sodium salt (calculated by dehydroacetic acid) were detected in buckwheat cold noodles may be that enterprises used it beyond the scope in order to extend the shelf life of the products or make up for the poor sanitary conditions in the production process.

　　XI. Peroxide value (in terms of fat)

　　Peroxide value is an early indicator of oil rancidity, which mainly reflects the degree of oil oxidation. Eating foods with excessive peroxide value will generally not cause harm to human health, but long-term consumption of foods with excessive peroxide value may lead to gastrointestinal discomfort and diarrhea. National Food Safety Standards for Pastry and Bread (GB 7099— 2015) stipulates that the maximum limit value of peroxide value (in terms of fat) in cakes is 0.25 g/100 g. The reason why the peroxide value (measured by fat) in cakes exceeds the standard value may be that the fat in raw materials has been oxidized, or it may be related to improper control of environmental conditions during storage and transportation.

　　XII. protein

　　Protein is a macromolecular organic compound with amino acids linked together by peptide bonds and forming a certain spatial structure. Protein is an important component of tissues and organs, a component of many important physiological active substances, and can also supply energy. National Food Safety Standard modified milk (GB 25191— In 2010), the protein content in modified milk should be ≥ 2.3 g/100g, and the product packaging label clearly States "high quality milk protein ≥ 3.7g/100mL ",after the unit conversion of test results, the test value of protein in this batch of products meets the national food safety standards, but it does not meet the express quality requirements of the products. The reason why the content of protein in dairy products is not up to standard may be that the quality control of raw and auxiliary materials is not strict, or that the enterprise fails to organize production according to the label or the requirements of enterprise standards.

　　Annex 2

　　CCTV News:Recently, official website, National Medical Products Administration released a message to revise the instructions for Qingkailing injection and Yiqifumai (freeze-drying) for injection. It is worth noting that Qingkailing injection, a large variety of Chinese patent medicine with an annual sales income of over 100 million yuan, clearly stipulates in the contraindications in the instructions that newborns, infants and pregnant women are prohibited.

　　The two drugs involved in the revision of the instructions belong to the category of traditional Chinese medicine injections, together with Shenmai injection, Bupleurum injection, Shuanghuanglian injection and Danshen injection previously announced, which is the announcement of the revision of the instructions for The 5th Wave traditional Chinese medicine injections issued by official website, National Medical Products Administration in 2018. What they have in common is that these traditional Chinese medicine injections are included in the "children’s forbidden list" to varying degrees, which should attract the attention of doctors and parents.

　　According to industry insiders, the revision of drug instructions is based on data such as adverse drug reaction monitoring, which is an inevitable trend of strengthening drug supervision and constantly standardizing clinical drug use, and should be more detailed and perfect. Take the adverse reactions in the modified instructions of Yiqi Fumai (freeze-drying) for injection as an example: the third item before the modification is "rare rash, chills and fever after using this product." If the above situation occurs, please stop taking the medicine immediately and deal with the symptoms. " After revision, the related contents of "3." under "Adverse Reactions" in the original manual were deleted, and nine items "Allergic reactions: skin flushing, rash, itching, dyspnea, palpitation, cyanosis, blood pressure drop, anaphylactoid reaction, anaphylactic shock, etc." were added. Systemic reactions: chills, fever, chills, chills, tremors, etc. Respiratory system: shortness of breath, breath holding, etc. Cardiovascular system: palpitation, chest tightness, elevated blood pressure, tachycardia, etc. Digestive system: nausea, vomiting and dry mouth. Neuropsychiatric system: dizziness, headache, tremor, irritability, local numbness, etc. Skin reactions: rash, itching, hyperhidrosis, local reactions, etc. Medication site: pain, injection site reaction, phlebitis, etc. Others: pain, fatigue, abnormal vision, menstrual disorder, etc. " Experts say that hospital pharmacists will report the adverse reactions in the process of clinical medication in time. The revised instructions list the adverse reactions in detail, which has played an important role in guiding clinical standardized drug use to some extent. (Reporter Zhang Ke)

　　(Professional Pharmaceutical Guidance: Director Lin Yang, Pharmacist Peng Wenxing, Department of Pharmacy, anzhen hospital, Beijing)

　　Attachment 1: Requirements for Revision of Instructions for Qingkailing Injection

　　First, warnings should be added, which should include:

　　Adverse reactions of this product include anaphylactic shock, which should be used in medical institutions with rescue conditions. Users should be trained in anaphylactic shock rescue, and allergic reactions or other serious adverse reactions after taking the drug should be stopped immediately and treated in time.

　　Two, [adverse reactions] shall include:

　　Allergic reaction: skin flushing or pallor, rash, itching, dyspnea, palpitation, cyanosis, blood pressure drop, laryngeal edema, anaphylactic shock, etc.

　　Systemic reactions: chills, chills, fever, high fever, pain, fatigue, hyperhidrosis, edema, trembling, etc.

　　Respiratory system: nasal congestion, sneezing, runny nose, throat discomfort, cough, wheezing, shortness of breath, dyspnea, etc.

　　Cardiovascular system: palpitation, chest tightness, chest pain, cyanosis, decreased or increased blood pressure, arrhythmia, etc.

　　Digestive system: nausea, vomiting, abdominal distension, abdominal pain, diarrhea, etc.

　　Neuropsychiatric system: dizziness, headache, irritability, convulsion, convulsion, syncope, tremor, confusion, coma, numbness of mouth and tongue or (and) limbs, drowsiness, insomnia, etc.

　　Skin and its accessories: redness, itching, rash, maculopapule, erythema, urticaria, local swelling, etc.

　　Vascular damage and coagulation disorders: mucosal congestion, purpura, phlebitis, etc.

　　Application site: pain, redness, rash, itching, etc.

　　Others: facial discomfort, tinnitus, abnormal tears, abnormal vision, eye congestion, myalgia, limb pain, herpes, hypokalemia, hematuria, etc.

　　Three, [taboo] should include:

　　1. Those who are allergic to this product or accessories listed in cholic acid, mother-of-pearl (powder), hyodeoxycholic acid, Gardenia, buffalo horn (powder), Radix Isatidis, baicalin and honeysuckle preparations and ingredients or have a history of serious adverse reactions are prohibited.

　　2. Newborns, infants and pregnant women are prohibited.

　　3. People with allergies are prohibited.

　　4. Persons with family allergy history are prohibited.

　　5. Those with hypokalemia including a history of periodic paralysis related to hypokalemia are prohibited.

　　Four, [matters needing attention] should include:

　　1. The adverse reactions of this product include anaphylactic shock, which should be used in medical institutions with rescue conditions. Users should be trained in anaphylactic shock rescue. If allergic reactions or other serious adverse reactions occur after taking the drug, the drug should be stopped immediately and treated in time.

　　2. Strictly follow the functional indications specified in the drug instructions, and prohibit the use of superfunctional indications.

　　3. Use in strict accordance with the recommended usage and dosage of the drug instructions, especially pay attention to not exceeding the dosage, too fast drip and long-term continuous medication.

　　4. Improper storage of this product may affect the quality of the drug. Before taking the drug, after preparation and during use, the product and the drip solution should be carefully checked. When the drug solution is found to have changes in drug properties such as turbidity, precipitation, discoloration and crystallization, as well as air leakage and cracks in the bottle body, it should not be used.

　　5. It is strictly forbidden to mix compatibility, and careful combination of drugs. This product should be used alone, and it is forbidden to mix with other drugs. If it is really necessary to use other drugs in combination, we should carefully consider the time interval and drug interaction with this product, and flush the infusion pipeline with appropriate diluent between the two drugs.

　　6. Patients should be carefully asked about their medication history and allergy history before medication. People with deficiency-cold constitution, those who use digitalis, patients with severe heart disease, patients with abnormal liver and kidney function, the elderly, lactating women and other special groups, as well as patients who use traditional Chinese medicine injections for the first time, should use them carefully and strengthen monitoring.

　　7. Strengthen medication monitoring. In the process of medication, the drug reaction should be closely observed, especially in the first 30 minutes. If any abnormality is found, stop taking medicine immediately and adopt active treatment measures to treat patients.

　　Attachment 2: Requirements for Revision of Instructions for Yiqi Fumai Injection (Freeze-dried)

　　First, warnings should be added, which should include:

　　Adverse reactions of this product include anaphylactic shock, which should be used in medical institutions with rescue conditions. Users should be trained in anaphylactic shock rescue, and allergic reactions or other serious adverse reactions after taking the drug should be stopped immediately and treated in time.

　　II. Item [Adverse Reaction] shall:

　　Delete the related contents of "3." under "Adverse Reactions" in the original manual and add the following contents:

　　3. Post-marketing monitoring data show that the following adverse reactions can be seen in this product:

　　Allergic reaction: skin flushing, rash, itching, dyspnea, palpitation, cyanosis, blood pressure drop, anaphylactoid reaction, anaphylactic shock, etc.

　　Systemic reactions: chills, fever, chills, chills, tremors, etc.

　　Respiratory system: shortness of breath, breath holding, etc.

　　Cardiovascular system: palpitation, chest tightness, elevated blood pressure, tachycardia, etc.

　　Digestive system: nausea, vomiting and dry mouth.

　　Neuropsychiatric system: dizziness, headache, tremor, irritability, local numbness, etc.

　　Skin reactions: rash, itching, hyperhidrosis, local reactions, etc.

　　Medication site: pain, injection site reaction, phlebitis, etc.

　　Others: pain, fatigue, abnormal vision, menstrual disorder, etc.

　　Three, [taboo] should add the following contents:

　　Those who are allergic to this product or accessories listed in preparations and ingredients containing Ginseng Radix Rubri, Radix Ophiopogonis and Fructus Schisandrae Chinensis or have a history of serious adverse reactions are prohibited.

　　Four, [notes] should be:

　　Delete the related contents of "3." under [Precautions] in the original manual and add the following contents:

　　1. The adverse reactions of this product include anaphylactic shock, which should be used in medical institutions with rescue conditions. Users should be trained in anaphylactic shock rescue. If allergic reactions or other serious adverse reactions occur after taking the drug, the drug should be stopped immediately and treated in time.

　　2. Strictly follow the functional indications specified in the drug instructions, and prohibit the use of superfunctional indications.

　　3. Use in strict accordance with the drug instructions, especially pay attention to not exceeding the dosage, too fast drip and long-term continuous medication.

　　4. It is strictly forbidden to mix compatibility, and careful combination of drugs. This product should be used alone, and it is forbidden to mix with other drugs. If it is really necessary to use other drugs in combination, we should carefully consider the time interval and drug interaction with this product, and flush the infusion pipeline with appropriate diluent between the two drugs.

　　5. Before taking the medicine, you should carefully ask about the allergic history, and it is forbidden for those with allergic constitution.

　　6. The elderly and patients who use traditional Chinese medicine injections for the first time should use them carefully and strengthen monitoring.

　　7. Strengthen medication monitoring. In the process of medication, the drug reaction should be closely observed, especially in the first 30 minutes. If any abnormality is found, stop taking medicine immediately and adopt active treatment measures to treat patients.

　　8. This product has a blood pressure increase reaction, so you should pay attention to the change of blood pressure when using this product.

　　9. This product should not be used with Veratrum nigrum, Oletum Trogopterori and their preparations.

CCTV News:In 2022, the National Health and Wellness Commission, as a pilot area of geriatric medical care services in 15 provinces including Beijing and Jiangsu, innovated and diversified geriatric medical care services and increased the supply of multi-level geriatric medical care services. In January, 2023, the first new type of nursing home with combination of medical care and nursing was officially put into operation in Jiangsu Province, which was embedded in a public nursing home in a community health service center. How is its operation in the past year? The reporter conducted a field interview.

Starting this year, Xu Guangqing, director of the Outang Community Service Center in Huishan District, Wuxi City, has another identity as the dean of the Outang Nursing Home.

Xu Guangqing, Director of Outang Community Health Service Center, Huishan District, Wuxi City, Dean of Outang Nursing Home:The biggest feature of our nursing home is medical empowerment for the elderly. In the original community health service center, we rely on more than 120 medical and nursing staff to empower the nursing home with basic medical care, rehabilitation and nursing. In space, the nursing home is close to the community health service center.

At 8 o’clock in the morning, the activity center on the third floor of Outang Nursing Home began to be lively. Many elderly people improved their physical function through exercises, games and other activities.

Zhou Yuhong, Therapist, Outang Nursing Home, Huishan District, Wuxi:Aunt Yu, who lives in bed 11 on the third floor, had great defects in language, cognition and physical coordination when she first came here. After three or four months of rehabilitation training, the limb function recovered obviously, and they were able to eat independently, and their cognitive function improved, and they were able to interact, communicate and play with other elderly people.

Aunt Yang’s parents are both in their eighties. The two old people originally lived separately. My father lived in a nursing home and my mother lived at home for the elderly. Aunt Yang herself is 64 years old, and it is very hard to take care of the elderly at both ends every day. Two months ago, Aunt Yang’s parents finally got together again in the Outang Nursing Home, and after exercise and rehabilitation, the old man’s physical function was greatly improved, and he often played chess with other old people, making his life more quality in his later years.

Ms. Yang, a resident of Huishan District, Wuxi City:When my dad came, he just slept in the bed and didn’t move. After coming, the doctors, nurses and nurses are all fine. They feel that they were not happy when they first came, but they were very happy when they came later. The rehabilitation teacher has been training him, interacting with him, playing games for him, and sometimes he will come down. So, we are also very happy, really happy.

At present, there are 119 beds in 3 nursing wards of Outang Nursing Home, which mainly treat the elderly with mobility difficulties and difficulties in self-care. Nursing homes share medical teams and equipment with community health service centers, so that the elderly can get integrated medical care, rehabilitation promotion, hospice care and other services.

Huishan District, Wuxi CityXu Guangqing, Director of Outang Community Health Service Center and Dean of Outang Nursing Home:At the same time, we rely on the medical community of Huishan District People’s Hospital. They also set up seven or eight specialist clinics here. In case of urgent trouble, we can make transshipment at 120. Secondly, it is convenient for them (doctors from Huishan District People’s Hospital) to come over, as long as it takes ten minutes, which makes the families of the elderly feel very at ease and assured.

Revitalize primary medical resources and support old and high-quality nursing resources

In Huishan District, Wuxi City, many elderly people need high-quality nursing resources, while there are 8 hospitals within 5 kilometers of Outang Community Health Service Center, and some primary medical and health institutions have idle beds and underutilized facilities and equipment. In this case, community hospitals are "embedded" in public nursing homes, which can be said to kill two birds with one stone.

Huishan District, Wuxi CityXu Guangqing, Director of Outang Community Health Service Center and Dean of Outang Nursing Home:Many resources of our original community health service center were idle. For example, the utilization rate of beds in our country is about 30%, and there are many medical staff who are usually responsible for some public health work, but there are still some time when they are free. The center is still a big pot model in terms of performance rewards. In fact, there is little difference between doing more and doing less. Therefore, many employees have no enthusiasm for work in this respect and are unwilling to pay more.

Although the Outang Community Health Service Center is small, it has complete departments and hardware, which can meet the diagnosis and treatment of common diseases and frequently-occurring diseases.

How can we use the idle equipment and beds in community health service centers? Increase income and motivate employees? After repeated investigations, many departments in Wuxi took the lead in issuing policies in Jiangsu Province to encourage qualified community health service centers (township hospitals) to set up new policies for nursing homes without changing their functions or increasing their establishment. Using the idle resources of community health service center, the breakthrough of public nursing home was realized. This new model runs according to the settlement mode of one legal person, one team, two medical institutions and two medical insurance.

Sheng Mingmin, Department of Primary Health and Health, Huishan District Health and Health Committee, Wuxi City:Considering that we should use this idle resource, we should also keep medical staff busy. The government fully considered embedding a nursing home in the community center. One can solve the problem of providing for the elderly in our jurisdiction, and at the same time improve the enthusiasm of medical staff.

The elderly can enjoy the basic medical insurance policy of settlement by bed day.

Setting up a public nursing home in the community health service center is a brand-new way for the community health service center, and it is even more good news for the surrounding elderly people. At present, the Outang Nursing Home in Huishan District, Wuxi City has officially opened, and has treated more than 350 elderly people and patients.

After the community health service center has added the medical care function, the elderly who live in the community can enjoy the basic medical insurance policy of bed settlement, and the elderly who meet the long-term care insurance can also enjoy 30-mdash every day; Subsidies for long-term care insurance in 50 yuan.

Huishan District, Wuxi CityXu Guangqing, Director of Outang Community Health Service Center and Dean of Outang Nursing Home:Wuxi’s policy is still relatively good. The medical insurance policy of nursing homes is to settle accounts by bed day. Every day, the government can have 100 yuan medical insurance support and 100% bed day settlement support. If you are a local patient, you can also enjoy reimbursement and subsidy policies such as long-term care insurance, and your own expenses will be less.

The innovation of the model has revived the health service center of Outang, which has been well received by patients and their families since the opening of the nursing home. At the same time, the business income of Outang Community Health Service Center has also been greatly improved, and the medical staff have also experienced the feeling of being busy and happy.

Huishan District, Wuxi CityXue Tingxian, Deputy Director of Nursing Department of Outang Community Health Service Center:In the past, the number of patients was almost maintained at around 20. Now, I am basically in the first and second nursing districts. Basically, the number of patients in the first nursing district is in the thirties, and the number of patients in the second nursing district is in the twenties, which is equivalent to the number of patients in a ward who have reached the previous center, and the number of people in the workload is doubled.

Xue Tingxian has just returned from studying in Zhongshan Geriatric Rehabilitation Hospital. For her, every day is a basic moment.

Huishan District, Wuxi CityXue Tingxian, Deputy Director of Nursing Department of Outang Community Health Service Center:Here (the patient’s condition) is basically severe, and the work is continuous, basically non-stop. The technical requirements are also relatively high. Through our going out to study and further study, our technical level can be greatly improved in all aspects.

Huishan District, Wuxi CityXu Guangqing, Director of Outang Community Health Service Center and Dean of Outang Nursing Home:Our assessment by the Health and Health Commission is totally different from the previous one, which may increase our performance by 5% to 10%.

After one year’s operation, the Outang Nursing Home has achieved a win-win effect, the elderly have been better cared for, the enthusiasm of medical staff has increased, and the business income of the community health service center has been greatly improved. Wuxi City said that on the basis of the pilot project of Outang Nursing Home, it will start the pilot project of public nursing homes in other areas one after another, and constantly explore more beneficial and effective experiences and measures for the combination of medical care and nursing.

1905 movie network news　Recently, the material poster was released by the anti-drug TV series "Hunting for Ice" directed by the director, and it was announced that it would be broadcast on February 21st. In the play, Huang Zongwei, the leader of drug manufacturing and trafficking, was played, which is another villain played by Zhang Songwen.

From the exposed materials, we can see that Zhang Songwen is holding a book on Advanced Organic Chemistry and wearing a suit in isolation, which reminds many netizens that Gao Qiqiang in The Knockout also learned brilliant strategies and decision-making methods because of the Art of War by Sun Tzu, and quipped: "A fishmonger doesn’t read the Art of War, but likes the chemistry textbook" and "Brother Qiang always armed himself with knowledge".